Motif 96 (n=129)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A4UGR9 | XIRP2 | S2348 | ochoa | Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin) | Protects actin filaments from depolymerization (PubMed:15454575). Required for correct morphology of cell membranes and maturation of intercalated disks of cardiomyocytes via facilitating localization of XIRP1 and CDH2 to the termini of aligned mature cardiomyocytes (By similarity). Thereby required for correct postnatal heart development and growth regulation that is crucial for overall heart morphology and diastolic function (By similarity). Required for normal electrical conduction in the heart including formation of the infranodal ventricular conduction system and normal action potential configuration, as a result of its interaction with the cardiac ion channel components Scn5a/Nav1.5 and Kcna5/Kv1.5 (By similarity). Required for regular actin filament spacing of the paracrystalline array in both inner and outer hair cells of the cochlea, thereby required for maintenance of stereocilia morphology (By similarity). {ECO:0000250|UniProtKB:Q4U4S6, ECO:0000269|PubMed:15454575}. |
A7KAX9 | ARHGAP32 | S952 | ochoa | Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP) | GTPase-activating protein (GAP) promoting GTP hydrolysis on RHOA, CDC42 and RAC1 small GTPases. May be involved in the differentiation of neuronal cells during the formation of neurite extensions. Involved in NMDA receptor activity-dependent actin reorganization in dendritic spines. May mediate cross-talks between Ras- and Rho-regulated signaling pathways in cell growth regulation. Isoform 2 has higher GAP activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:12446789, ECO:0000269|PubMed:12454018, ECO:0000269|PubMed:12531901, ECO:0000269|PubMed:12788081, ECO:0000269|PubMed:12819203, ECO:0000269|PubMed:12857875, ECO:0000269|PubMed:17663722}. |
O00159 | MYO1C | S592 | ochoa | Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) | Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Involved in glucose transporter recycling in response to insulin by regulating movement of intracellular GLUT4-containing vesicles to the plasma membrane. Component of the hair cell's (the sensory cells of the inner ear) adaptation-motor complex. Acts as a mediator of adaptation of mechanoelectrical transduction in stereocilia of vestibular hair cells. Binds phosphoinositides and links the actin cytoskeleton to cellular membranes. {ECO:0000269|PubMed:24636949}.; FUNCTION: [Isoform 3]: Involved in regulation of transcription. Associated with transcriptional active ribosomal genes. Appears to cooperate with the WICH chromatin-remodeling complex to facilitate transcription. Necessary for the formation of the first phosphodiester bond during transcription initiation. {ECO:0000250|UniProtKB:Q9WTI7}. |
O14531 | DPYSL4 | S542 | ochoa | Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4) | Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration (By similarity). {ECO:0000250}. |
O43303 | CCP110 | S551 | ochoa | Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110) | Necessary for centrosome duplication at different stages of procentriole formation. Acts as a key negative regulator of ciliogenesis in collaboration with CEP97 by capping the mother centriole thereby preventing cilia formation (PubMed:17681131, PubMed:17719545, PubMed:23486064, PubMed:30375385, PubMed:35301795). Also involved in promoting ciliogenesis. May play a role in the assembly of the mother centriole subdistal appendages (SDA) thereby effecting the fusion of recycling endosomes to basal bodies during cilia formation (By similarity). Required for correct spindle formation and has a role in regulating cytokinesis and genome stability via cooperation with CALM1 and CETN2 (PubMed:16760425). {ECO:0000250|UniProtKB:Q7TSH4, ECO:0000269|PubMed:12361598, ECO:0000269|PubMed:16760425, ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:23486064, ECO:0000269|PubMed:30375385, ECO:0000269|PubMed:35301795}. |
O43670 | ZNF207 | S346 | ochoa | BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207) | Kinetochore- and microtubule-binding protein that plays a key role in spindle assembly (PubMed:24462186, PubMed:24462187, PubMed:26388440). ZNF207/BuGZ is mainly composed of disordered low-complexity regions and undergoes phase transition or coacervation to form temperature-dependent liquid droplets. Coacervation promotes microtubule bundling and concentrates tubulin, promoting microtubule polymerization and assembly of spindle and spindle matrix by concentrating its building blocks (PubMed:26388440). Also acts as a regulator of mitotic chromosome alignment by mediating the stability and kinetochore loading of BUB3 (PubMed:24462186, PubMed:24462187). Mechanisms by which BUB3 is protected are unclear: according to a first report, ZNF207/BuGZ may act by blocking ubiquitination and proteasomal degradation of BUB3 (PubMed:24462186). According to another report, the stabilization is independent of the proteasome (PubMed:24462187). {ECO:0000269|PubMed:24462186, ECO:0000269|PubMed:24462187, ECO:0000269|PubMed:26388440}. |
O95789 | ZMYM6 | S397 | ochoa | Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258) | Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:21834987}. |
O95985 | TOP3B | S788 | ochoa | DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1) | Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity. {ECO:0000250}. |
P04004 | VTN | S312 | ochoa|psp | Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B] | Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.; FUNCTION: Somatomedin-B is a growth hormone-dependent serum factor with protease-inhibiting activity. |
P07384 | CAPN1 | S93 | ochoa | Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP) | Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction (PubMed:19617626, PubMed:21531719, PubMed:2400579). Proteolytically cleaves CTBP1 at 'Asn-375', 'Gly-387' and 'His-409' (PubMed:23707407). Cleaves and activates caspase-7 (CASP7) (PubMed:19617626). {ECO:0000269|PubMed:19617626, ECO:0000269|PubMed:21531719, ECO:0000269|PubMed:23707407, ECO:0000269|PubMed:2400579}. |
P11055 | MYH3 | S174 | ochoa | Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE) | Muscle contraction. |
P12882 | MYH1 | S174 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12883 | MYH7 | S19 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P12883 | MYH7 | S173 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P13533 | MYH6 | S173 | ochoa | Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha) | Muscle contraction. |
P13535 | MYH8 | S176 | ochoa | Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal) | Muscle contraction. |
P15172 | MYOD1 | S278 | psp | Myoblast determination protein 1 (Class C basic helix-loop-helix protein 1) (bHLHc1) (Myogenic factor 3) (Myf-3) | Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins (By similarity). {ECO:0000250}. |
P15735 | PHKG2 | S269 | ochoa | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) | Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. May regulate glycogeneolysis in the testis. In vitro, phosphorylates PYGM (PubMed:35549678). {ECO:0000250|UniProtKB:P31325, ECO:0000269|PubMed:10487978, ECO:0000269|PubMed:35549678}. |
P15822 | HIVEP1 | S670 | ochoa | Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV-1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, and interferon-beta genes. It may act in T-cell activation. Involved in activating HIV-1 gene expression. Isoform 2 and isoform 3 also bind to the IPCS (IRF1 and p53 common sequence) DNA sequence in the promoter region of interferon regulatory factor 1 and p53 genes and are involved in transcription regulation of these genes. Isoform 2 does not activate HIV-1 gene expression. Isoform 2 and isoform 3 may be involved in apoptosis. |
P15884 | TCF4 | S198 | ochoa | Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2) | Transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5-motif. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3'). Binds to the E-box present in the somatostatin receptor 2 initiator element (SSTR2-INR) to activate transcription (By similarity). Preferentially binds to either 5'-ACANNTGT-3' or 5'-CCANNTGG-3'. {ECO:0000250}. |
P15924 | DSP | S2526 | ochoa | Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen) | Major high molecular weight protein of desmosomes. Regulates profibrotic gene expression in cardiomyocytes via activation of the MAPK14/p38 MAPK signaling cascade and increase in TGFB1 protein abundance (By similarity). {ECO:0000250|UniProtKB:F1LMV6}. |
P21802 | FGFR2 | S452 | ochoa | Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332) | Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. {ECO:0000269|PubMed:12529371, ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:15629145, ECO:0000269|PubMed:16384934, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18374639, ECO:0000269|PubMed:19103595, ECO:0000269|PubMed:19387476, ECO:0000269|PubMed:19410646, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:8663044}. |
P25054 | APC | S1238 | ochoa | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000250|UniProtKB:Q61315, ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17293347, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}. |
P30414 | NKTR | S1200 | ochoa | NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR) (PPIase) (EC 5.2.1.8) (Rotamase) | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding (PubMed:20676357). Component of a putative tumor-recognition complex involved in the function of NK cells (PubMed:8421688). {ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:8421688}. |
P31629 | HIVEP2 | S565 | ochoa | Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon-beta genes. It may act in T-cell activation. |
P32322 | PYCR1 | S109 | ochoa | Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2) | Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H (PubMed:16730026, PubMed:19648921, PubMed:23024808, PubMed:28258219). At physiologic concentrations, has higher specific activity in the presence of NADH (PubMed:16730026, PubMed:23024808). Involved in the cellular response to oxidative stress (PubMed:16730026, PubMed:19648921). {ECO:0000269|PubMed:16730026, ECO:0000269|PubMed:19648921, ECO:0000269|PubMed:23024808, ECO:0000269|PubMed:28258219}. |
P32519 | ELF1 | S542 | ochoa | ETS-related transcription factor Elf-1 (E74-like factor 1) | Transcription factor that activates the LYN and BLK promoters. Appears to be required for the T-cell-receptor-mediated trans activation of HIV-2 gene expression. Binds specifically to two purine-rich motifs in the HIV-2 enhancer. {ECO:0000269|PubMed:8756667}. |
P33993 | MCM7 | S483 | ochoa | DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P35269 | GTF2F1 | S396 | ochoa | General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74) | TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation. {ECO:0000269|PubMed:10428810}. |
P46087 | NOP2 | S594 | ochoa | 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120) | S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the C(5) position of cytosine 4447 in 28S rRNA (PubMed:26196125). Required for efficient rRNA processing and 60S ribosomal subunit biogenesis (PubMed:24120868, PubMed:36161484). Regulates pre-rRNA processing through non-catalytic complex formation with box C/D snoRNAs and facilitates the recruitment of U3 and U8 snoRNAs to pre-90S ribosomal particles and their stable assembly into snoRNP complexes (PubMed:36161484). May play a role in the regulation of the cell cycle and the increased nucleolar activity that is associated with the cell proliferation (PubMed:24120868). {ECO:0000269|PubMed:24120868, ECO:0000269|PubMed:26196125, ECO:0000269|PubMed:36161484}. |
P46821 | MAP1B | S1501 | ochoa | Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] | Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing. {ECO:0000250, ECO:0000269|PubMed:18195017, ECO:0000269|PubMed:33268592}. |
P49327 | FASN | S2123 | ochoa | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.; FUNCTION: (Microbial infection) Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. {ECO:0000269|PubMed:34320401}. |
P49790 | NUP153 | S1046 | ochoa | Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) | Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with TPR, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Mediates TPR anchoring to the nuclear membrane at NPC. The repeat-containing domain may be involved in anchoring other components of the NPC to the pore membrane. Possible DNA-binding subunit of the nuclear pore complex (NPC). {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:22253824}.; FUNCTION: (Microbial infection) Interacts with HIV-1 caspid protein P24 and thereby promotes the integration of the virus in the nucleus of non-dividing cells (in vitro). {ECO:0000269|PubMed:23523133, ECO:0000269|PubMed:24130490, ECO:0000269|PubMed:29997211}.; FUNCTION: (Microbial infection) Binds HIV-2 protein vpx and thereby promotes the nuclear translocation of the lentiviral genome (in vitro). {ECO:0000269|PubMed:24130490, ECO:0000269|PubMed:31913756}. |
P52179 | MYOM1 | S220 | ochoa | Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P52594 | AGFG1 | S292 | ochoa | Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein) | Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication. {ECO:0000250, ECO:0000269|PubMed:10613896, ECO:0000269|PubMed:14701878, ECO:0000269|PubMed:15749819}. |
P53814 | SMTN | S690 | ochoa | Smoothelin | Structural protein of the cytoskeleton. |
P78369 | CLDN10 | S199 | ochoa | Claudin-10 (Oligodendrocyte-specific protein-like) (OSP-like) | Forms paracellular channels: polymerizes in tight junction strands with cation- and anion-selective channels through the strands, conveying epithelial permeability in a process known as paracellular tight junction permeability. {ECO:0000269|PubMed:19383724, ECO:0000269|PubMed:28686597, ECO:0000269|PubMed:35650657, ECO:0000269|PubMed:36008380}.; FUNCTION: [Isoform 1]: Forms cation-selective paracellular channels. In sweat glands and in the thick ascending limb (TAL) of Henle's loop in kidney, it controls paracellular sodium permeability which is essential for proper sweat production and renal function (PubMed:19383724, PubMed:28686597, PubMed:28771254, PubMed:35650657, PubMed:36008380). {ECO:0000269|PubMed:19383724, ECO:0000269|PubMed:28686597, ECO:0000269|PubMed:28771254, ECO:0000269|PubMed:35650657, ECO:0000269|PubMed:36008380}.; FUNCTION: [Isoform 2]: Forms anion-selective paracellular channels. In renal proximal tubules, it conveys selective chloride over hydrogencarbonate anion permeability which is required for renal chloride reabsorption and salt homeostasis. {ECO:0000250|UniProtKB:Q9Z0S6, ECO:0000269|PubMed:19383724, ECO:0000269|PubMed:36008380}. |
P78527 | PRKDC | S2041 | psp | DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (Ser-473 kinase) (S473K) (p460) | Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326, PubMed:33854234). Acts as a scaffold protein to aid the localization of DNA repair proteins to the site of damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Recognizes the substrate consensus sequence [ST]-Q (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism (PubMed:14627815, PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 (PubMed:10026262, PubMed:10467406, PubMed:11889123, PubMed:12509254, PubMed:14599745, PubMed:14612514, PubMed:14704337, PubMed:15177042, PubMed:1597196, PubMed:16397295, PubMed:18644470, PubMed:2247066, PubMed:2507541, PubMed:26237645, PubMed:26666690, PubMed:28712728, PubMed:29478807, PubMed:30247612, PubMed:8407951, PubMed:8464713, PubMed:9139719, PubMed:9362500). Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D (PubMed:9363941). Acts as a regulator of the phosphatidylinositol 3-kinase/protein kinase B signal transduction by mediating phosphorylation of 'Ser-473' of protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), promoting their activation (PubMed:15262962). Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 (PubMed:35460603). {ECO:0000250|UniProtKB:P97313, ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123, ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12509254, ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14599745, ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:15177042, ECO:0000269|PubMed:15262962, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194, ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:18644470, ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541, ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:26666690, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:30247612, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33854234, ECO:0000269|PubMed:34352203, ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:8407951, ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:9139719, ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941, ECO:0000269|PubMed:9679063}. |
Q02241 | KIF23 | S160 | ochoa | Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) | Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Essential for cytokinesis in Rho-mediated signaling. Required for the localization of ECT2 to the central spindle. Plus-end-directed motor enzyme that moves antiparallel microtubules in vitro. {ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:22522702, ECO:0000269|PubMed:23570799}. |
Q03164 | KMT2A | S3216 | ochoa | Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] | Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:24235145, PubMed:26886794). Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:25561738, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' (PubMed:19187761). Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20010842, PubMed:20677832). Promotes PPP1R15A-induced apoptosis (PubMed:10490642). Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate (PubMed:24235145). {ECO:0000250|UniProtKB:P55200, ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:12453419, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:19187761, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20010842, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:24235145, ECO:0000269|PubMed:26886794, ECO:0000305|PubMed:20677832}. |
Q04864 | REL | S492 | psp | Proto-oncogene c-Rel | Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator. |
Q04864 | REL | S557 | psp | Proto-oncogene c-Rel | Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator. |
Q12955 | ANK3 | S539 | ochoa | Ankyrin-3 (ANK-3) (Ankyrin-G) | Membrane-cytoskeleton linker. May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments (PubMed:7836469). In skeletal muscle, required for costamere localization of DMD and betaDAG1 (By similarity). Regulates KCNA1 channel activity in function of dietary Mg(2+) levels, and thereby contributes to the regulation of renal Mg(2+) reabsorption (PubMed:23903368). Required for intracellular adhesion and junctional conductance in myocytes, potentially via stabilization of GJA1/CX43 protein abundance and promotion of PKP2, GJA1/CX43, and SCN5A/Nav1.5 localization to cell-cell junctions (By similarity). {ECO:0000250|UniProtKB:G5E8K5, ECO:0000250|UniProtKB:O70511, ECO:0000269|PubMed:23903368, ECO:0000269|PubMed:7836469}.; FUNCTION: [Isoform 5]: May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin. {ECO:0000305|PubMed:17974005}. |
Q13009 | TIAM1 | S370 | ochoa | Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1) (TIAM-1) | Guanyl-nucleotide exchange factor that activates RHO-like proteins and connects extracellular signals to cytoskeletal activities. Activates RAC1, CDC42, and to a lesser extent RHOA and their downstream signaling to regulate processes like cell adhesion and cell migration. {ECO:0000269|PubMed:20361982, ECO:0000269|PubMed:25684205}. |
Q13309 | SKP2 | S256 | psp | S-phase kinase-associated protein 2 (Cyclin-A/CDK2-associated protein p45) (F-box protein Skp2) (F-box/LRR-repeat protein 1) (p45skp2) | Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle progression, signal transduction and transcription (PubMed:9736735, PubMed:11931757, PubMed:12435635, PubMed:12769844, PubMed:12840033, PubMed:15342634, PubMed:15668399, PubMed:15949444, PubMed:16103164, PubMed:16262255, PubMed:16581786, PubMed:16951159, PubMed:17908926, PubMed:17962192, PubMed:22464731, PubMed:22770219, PubMed:32267835). Specifically recognizes phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S transition (By similarity). Degradation of CDKN1B/p27kip also requires CKS1 (By similarity). Recognizes target proteins ORC1, CDT1, RBL2, KMT2A/MLL1, CDK9, RAG2, NBN, FOXO1, UBP43, YTHDF2, and probably MYC, TOB1 and TAL1 (PubMed:11931757, PubMed:12435635, PubMed:12769844, PubMed:12840033, PubMed:15342634, PubMed:15668399, PubMed:15949444, PubMed:16103164, PubMed:16581786, PubMed:16951159, PubMed:17908926, PubMed:17962192, PubMed:22464731, PubMed:32267835). Degradation of TAL1 also requires STUB1 (PubMed:17962192). Recognizes CDKN1A in association with CCNE1 or CCNE2 and CDK2 (PubMed:9736735, PubMed:16262255). Promotes ubiquitination and destruction of CDH1 in a CK1-dependent manner, thereby regulating cell migration (PubMed:22770219). Following phosphorylation in response to DNA damage, mediates 'Lys-63'-linked ubiquitination of NBN, promoting ATM recruitment to DNA damage sites and DNA repair via homologous recombination (PubMed:22464731). {ECO:0000250|UniProtKB:Q9Z0Z3, ECO:0000269|PubMed:11931757, ECO:0000269|PubMed:12435635, ECO:0000269|PubMed:12769844, ECO:0000269|PubMed:12840033, ECO:0000269|PubMed:15342634, ECO:0000269|PubMed:15668399, ECO:0000269|PubMed:15949444, ECO:0000269|PubMed:16103164, ECO:0000269|PubMed:16262255, ECO:0000269|PubMed:16581786, ECO:0000269|PubMed:16951159, ECO:0000269|PubMed:17908926, ECO:0000269|PubMed:17962192, ECO:0000269|PubMed:22464731, ECO:0000269|PubMed:22770219, ECO:0000269|PubMed:32267835, ECO:0000269|PubMed:9736735}.; FUNCTION: Through the ubiquitin-mediated proteasomal degradation of hepatitis C virus non-structural protein 5A, has an antiviral activity towards that virus. {ECO:0000269|PubMed:27194766}. |
Q13426 | XRCC4 | S259 | ochoa | DNA repair protein XRCC4 (hXRCC4) (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus (XRCC4/C)] | [DNA repair protein XRCC4]: DNA non-homologous end joining (NHEJ) core factor, required for double-strand break repair and V(D)J recombination (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:16412978, PubMed:17124166, PubMed:17290226, PubMed:22228831, PubMed:25597996, PubMed:25742519, PubMed:25934149, PubMed:26100018, PubMed:26774286, PubMed:8548796). Acts as a scaffold protein that regulates recruitment of other proteins to DNA double-strand breaks (DSBs) (PubMed:15385968, PubMed:20852255, PubMed:26774286, PubMed:27437582). Associates with NHEJ1/XLF to form alternating helical filaments that bridge DNA and act like a bandage, holding together the broken DNA until it is repaired (PubMed:21768349, PubMed:21775435, PubMed:22287571, PubMed:26100018, PubMed:27437582, PubMed:28500754). The XRCC4-NHEJ1/XLF subcomplex binds to the DNA fragments of a DSB in a highly diffusive manner and robustly bridges two independent DNA molecules, holding the broken DNA fragments in close proximity to one other (PubMed:27437582). The mobility of the bridges ensures that the ends remain accessible for further processing by other repair factors (PubMed:27437582). Plays a key role in the NHEJ ligation step of the broken DNA during DSB repair via direct interaction with DNA ligase IV (LIG4): the LIG4-XRCC4 subcomplex reseals the DNA breaks after the gap filling is completed (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:17290226, PubMed:19837014, PubMed:9242410). XRCC4 stabilizes LIG4, regulates its subcellular localization and enhances LIG4's joining activity (PubMed:10757784, PubMed:10854421, PubMed:12517771, PubMed:17290226, PubMed:21982441, PubMed:22228831, PubMed:9242410). Binding of the LIG4-XRCC4 subcomplex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends (PubMed:10757784, PubMed:10854421). Promotes displacement of PNKP from processed strand break termini (PubMed:20852255, PubMed:28453785). {ECO:0000269|PubMed:10757784, ECO:0000269|PubMed:10854421, ECO:0000269|PubMed:12517771, ECO:0000269|PubMed:15385968, ECO:0000269|PubMed:16412978, ECO:0000269|PubMed:17124166, ECO:0000269|PubMed:17290226, ECO:0000269|PubMed:19837014, ECO:0000269|PubMed:20852255, ECO:0000269|PubMed:21768349, ECO:0000269|PubMed:21775435, ECO:0000269|PubMed:21982441, ECO:0000269|PubMed:22228831, ECO:0000269|PubMed:22287571, ECO:0000269|PubMed:25597996, ECO:0000269|PubMed:25742519, ECO:0000269|PubMed:25934149, ECO:0000269|PubMed:26100018, ECO:0000269|PubMed:26774286, ECO:0000269|PubMed:27437582, ECO:0000269|PubMed:28453785, ECO:0000269|PubMed:28500754, ECO:0000269|PubMed:8548796, ECO:0000269|PubMed:9242410}.; FUNCTION: [Protein XRCC4, C-terminus]: Acts as an activator of the phospholipid scramblase activity of XKR4 (PubMed:33725486). This form, which is generated upon caspase-3 (CASP3) cleavage, translocates into the cytoplasm and interacts with XKR4, thereby promoting phosphatidylserine scramblase activity of XKR4 and leading to phosphatidylserine exposure on apoptotic cell surface (PubMed:33725486). {ECO:0000269|PubMed:33725486}. |
Q14157 | UBAP2L | S340 | ochoa | Ubiquitin-associated protein 2-like (Protein NICE-4) (RNA polymerase II degradation factor UBAP2L) | Recruits the ubiquitination machinery to RNA polymerase II for polyubiquitination, removal and degradation, when the transcription-coupled nucleotide excision repair (TC-NER) machinery fails to resolve DNA damage (PubMed:35633597). Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (By similarity). Is a regulator of stress granule assembly, required for their efficient formation (PubMed:29395067, PubMed:35977029). Required for proper brain development and neocortex lamination (By similarity). {ECO:0000250|UniProtKB:Q80X50, ECO:0000269|PubMed:29395067, ECO:0000269|PubMed:35633597}. |
Q14207 | NPAT | S1151 | ochoa | Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus) (Nuclear protein of the ATM locus) (p220) | Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters. {ECO:0000269|PubMed:10995386, ECO:0000269|PubMed:10995387, ECO:0000269|PubMed:12665581, ECO:0000269|PubMed:12724424, ECO:0000269|PubMed:14585971, ECO:0000269|PubMed:14612403, ECO:0000269|PubMed:15555599, ECO:0000269|PubMed:15988025, ECO:0000269|PubMed:16131487, ECO:0000269|PubMed:17163457, ECO:0000269|PubMed:17826007, ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:17974976, ECO:0000269|PubMed:9472014}. |
Q15700 | DLG2 | S65 | ochoa | Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93) | Required for perception of chronic pain through NMDA receptor signaling. Regulates surface expression of NMDA receptors in dorsal horn neurons of the spinal cord. Interacts with the cytoplasmic tail of NMDA receptor subunits as well as inward rectifying potassium channels. Involved in regulation of synaptic stability at cholinergic synapses. Part of the postsynaptic protein scaffold of excitatory synapses (By similarity). {ECO:0000250}. |
Q5JWR5 | DOP1A | S1267 | ochoa | Protein DOP1A | May be involved in protein traffic between late Golgi and early endosomes. {ECO:0000250|UniProtKB:Q03921}. |
Q5SVZ6 | ZMYM1 | S387 | ochoa | Zinc finger MYM-type protein 1 | None |
Q5T1R4 | HIVEP3 | S1437 | ochoa | Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1) (KBP-1) (Zinc finger protein ZAS3) | Plays a role of transcription factor; binds to recognition signal sequences (Rss heptamer) for somatic recombination of immunoglobulin and T-cell receptor gene segments; Also binds to the kappa-B motif of gene such as S100A4, involved in cell progression and differentiation. Kappa-B motif is a gene regulatory element found in promoters and enhancers of genes involved in immunity, inflammation, and growth and that responds to viral antigens, mitogens, and cytokines. Involvement of HIVEP3 in cell growth is strengthened by the fact that its down-regulation promotes cell cycle progression with ultimate formation of multinucleated giant cells. Strongly inhibits TNF-alpha-induced NF-kappa-B activation; Interferes with nuclear factor NF-kappa-B by several mechanisms: as transcription factor, by competing for Kappa-B motif and by repressing transcription in the nucleus; through a non transcriptional process, by inhibiting nuclear translocation of RELA by association with TRAF2, an adapter molecule in the tumor necrosis factor signaling, which blocks the formation of IKK complex. Interaction with TRAF proteins inhibits both NF-Kappa-B-mediated and c-Jun N-terminal kinase/JNK-mediated responses that include apoptosis and pro-inflammatory cytokine gene expression. Positively regulates the expression of IL2 in T-cell. Essential regulator of adult bone formation. {ECO:0000269|PubMed:11161801}. |
Q5T5P2 | KIAA1217 | S610 | ochoa | Sickle tail protein homolog | Required for normal development of intervertebral disks. {ECO:0000250|UniProtKB:A2AQ25}. |
Q5T5P2 | KIAA1217 | S1245 | ochoa | Sickle tail protein homolog | Required for normal development of intervertebral disks. {ECO:0000250|UniProtKB:A2AQ25}. |
Q5T5Y3 | CAMSAP1 | S862 | ochoa | Calmodulin-regulated spectrin-associated protein 1 | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:19508979, PubMed:21834987, PubMed:24117850, PubMed:24486153, PubMed:24706919). Specifically recognizes growing microtubule minus-ends and stabilizes microtubules (PubMed:24486153, PubMed:24706919). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153, PubMed:24706919). In contrast to CAMSAP2 and CAMSAP3, tracks along the growing tips of minus-end microtubules without significantly affecting the polymerization rate: binds at the very tip of the microtubules minus-end and acts as a minus-end tracking protein (-TIP) that dissociates from microtubules after allowing tubulin incorporation (PubMed:24486153, PubMed:24706919). Through interaction with spectrin may regulate neurite outgrowth (PubMed:24117850). {ECO:0000269|PubMed:19508979, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:24117850, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919}. |
Q5UIP0 | RIF1 | S2006 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5VTR2 | RNF20 | S172 | psp | E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A) | Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role inb histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. Recruited to the MDM2 promoter, probably by being recruited by p53/TP53, and thereby acts as a transcriptional coactivator. Mediates the polyubiquitination of isoform 2 of PA2G4 in cancer cells leading to its proteasome-mediated degradation. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:16337599, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19410543}.; FUNCTION: (Microbial infection) Promotes the human herpesvirus 8 (KSHV) lytic cycle by inducing the expression of lytic viral genes including the latency switch gene RTA/ORF50. {ECO:0000269|PubMed:37888983}. |
Q63HK5 | TSHZ3 | S835 | ochoa | Teashirt homolog 3 (Zinc finger protein 537) | Transcriptional regulator involved in developmental processes. Functions in association with APBB1, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. TSHZ3-mediated transcription repression involves the recruitment of histone deacetylases HDAC1 and HDAC2. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s) (PubMed:19343227). Regulates the development of neurons involved in both respiratory rhythm and airflow control. Promotes maintenance of nucleus ambiguus (nA) motoneurons, which govern upper airway function, and establishes a respiratory rhythm generator (RRG) activity compatible with survival at birth. Involved in the differentiation of the proximal uretic smooth muscle cells during developmental processes. Involved in the up-regulation of myocardin, that directs the expression of smooth muscle cells in the proximal ureter (By similarity). Involved in the modulation of glutamatergic synaptic transmission and long-term synaptic potentiation (By similarity). {ECO:0000250|UniProtKB:Q8CGV9, ECO:0000269|PubMed:19343227}. |
Q68EM7 | ARHGAP17 | S840 | ochoa | Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) | Rho GTPase-activating protein involved in the maintenance of tight junction by regulating the activity of CDC42, thereby playing a central role in apical polarity of epithelial cells. Specifically acts as a GTPase activator for the CDC42 GTPase by converting it to an inactive GDP-bound state. The complex formed with AMOT acts by regulating the uptake of polarity proteins at tight junctions, possibly by deciding whether tight junction transmembrane proteins are recycled back to the plasma membrane or sent elsewhere. Participates in the Ca(2+)-dependent regulation of exocytosis, possibly by catalyzing GTPase activity of Rho family proteins and by inducing the reorganization of the cortical actin filaments. Acts as a GTPase activator in vitro for RAC1. {ECO:0000269|PubMed:11431473, ECO:0000269|PubMed:16678097}. |
Q6WKZ4 | RAB11FIP1 | S754 | ochoa | Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein) | A Rab11 effector protein involved in the endosomal recycling process. Also involved in controlling membrane trafficking along the phagocytic pathway and in phagocytosis. Interaction with RAB14 may function in the process of neurite formation (PubMed:26032412). {ECO:0000269|PubMed:11786538, ECO:0000269|PubMed:15181150, ECO:0000269|PubMed:15355514, ECO:0000269|PubMed:16920206, ECO:0000269|PubMed:26032412}. |
Q6ZN18 | AEBP2 | S241 | ochoa | Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2) | Acts as an accessory subunit for the core Polycomb repressive complex 2 (PRC2), which mediates histone H3K27 (H3K27me3) trimethylation on chromatin leading to transcriptional repression of the affected target gene (PubMed:15225548, PubMed:29499137, PubMed:31959557). Plays a role in nucleosome localization of the PRC2 complex (PubMed:29499137). {ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:29499137, ECO:0000269|PubMed:31959557}. |
Q7Z6E9 | RBBP6 | S1462 | ochoa | E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis) | E3 ubiquitin-protein ligase which promotes ubiquitination of YBX1, leading to its degradation by the proteasome (PubMed:18851979). May play a role as a scaffold protein to promote the assembly of the p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated ubiquitination and degradation of p53/TP53; may function as negative regulator of p53/TP53, leading to both apoptosis and cell growth (By similarity). Regulates DNA-replication and the stability of chromosomal common fragile sites (CFSs) in a ZBTB38- and MCM10-dependent manner. Controls ZBTB38 protein stability and abundance via ubiquitination and proteasomal degradation, and ZBTB38 in turn negatively regulates the expression of MCM10 which plays an important role in DNA-replication (PubMed:24726359). {ECO:0000250|UniProtKB:P97868, ECO:0000269|PubMed:18851979, ECO:0000269|PubMed:24726359}.; FUNCTION: (Microbial infection) [Isoform 1]: Restricts ebolavirus replication probably by impairing the vp30-NP interaction, and thus viral transcription. {ECO:0000269|PubMed:30550789}. |
Q86T90 | KIAA1328 | S26 | ochoa | Protein hinderin | Competes with SMC1 for binding to SMC3. May affect the availability of SMC3 to engage in the formation of multimeric protein complexes. {ECO:0000269|PubMed:15656913}. |
Q86UR5 | RIMS1 | S1450 | ochoa | Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1) (RIM 1) (Rab-3-interacting protein 2) | Rab effector involved in exocytosis (By similarity). May act as scaffold protein that regulates neurotransmitter release at the active zone. Essential for maintaining normal probability of neurotransmitter release and for regulating release during short-term synaptic plasticity (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000250|UniProtKB:Q99NE5, ECO:0000269|PubMed:23999003}. |
Q86UW6 | N4BP2 | S1216 | ochoa | NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein) | Has 5'-polynucleotide kinase and nicking endonuclease activity. May play a role in DNA repair or recombination. {ECO:0000269|PubMed:12730195}. |
Q8IU85 | CAMK1D | S358 | ochoa | Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) | Calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium influx, activates CREB-dependent gene transcription, regulates calcium-mediated granulocyte function and respiratory burst and promotes basal dendritic growth of hippocampal neurons. In neutrophil cells, required for cytokine-induced proliferative responses and activation of the respiratory burst. Activates the transcription factor CREB1 in hippocampal neuron nuclei. May play a role in apoptosis of erythroleukemia cells. In vitro, phosphorylates transcription factor CREM isoform Beta. {ECO:0000269|PubMed:11050006, ECO:0000269|PubMed:15840691, ECO:0000269|PubMed:16324104, ECO:0000269|PubMed:17056143}. |
Q8IV32 | CCDC71 | S144 | ochoa | Coiled-coil domain-containing protein 71 | None |
Q8IVF2 | AHNAK2 | S1710 | ochoa | Protein AHNAK2 | None |
Q8IVF2 | AHNAK2 | S4185 | ochoa | Protein AHNAK2 | None |
Q8IVF5 | TIAM2 | S1545 | ochoa | Rho guanine nucleotide exchange factor TIAM2 (SIF and TIAM1-like exchange factor) (T-lymphoma invasion and metastasis-inducing protein 2) (TIAM-2) | Modulates the activity of RHO-like proteins and connects extracellular signals to cytoskeletal activities. Acts as a GDP-dissociation stimulator protein that stimulates the GDP-GTP exchange activity of RHO-like GTPases and activates them. Mediates extracellular laminin signals to activate Rac1, contributing to neurite growth. Involved in lamellipodial formation and advancement of the growth cone of embryonic hippocampal neurons. Promotes migration of neurons in the cerebral cortex. When overexpressed, induces membrane ruffling accompanied by the accumulation of actin filaments along the altered plasma membrane (By similarity). Activates specifically RAC1, but not CDC42 and RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}. |
Q8IVL0 | NAV3 | S1727 | ochoa | Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3) (unc53H3) | Plays a role in cell migration (PubMed:21471154). May be involved in neuron regeneration. May regulate IL2 production by T-cells. {ECO:0000269|PubMed:16166283, ECO:0000269|PubMed:21471154}. |
Q8IYD8 | FANCM | S1758 | ochoa | Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog) | DNA-dependent ATPase component of the Fanconi anemia (FA) core complex (PubMed:16116422). Required for the normal activation of the FA pathway, leading to monoubiquitination of the FANCI-FANCD2 complex in response to DNA damage, cellular resistance to DNA cross-linking drugs, and prevention of chromosomal breakage (PubMed:16116422, PubMed:19423727, PubMed:20347428, PubMed:20347429, PubMed:29231814). In complex with CENPS and CENPX, binds double-stranded DNA (dsDNA), fork-structured DNA (fsDNA) and Holliday junction substrates (PubMed:20347428, PubMed:20347429). Its ATP-dependent DNA branch migration activity can process branched DNA structures such as a movable replication fork. This activity is strongly stimulated in the presence of CENPS and CENPX (PubMed:20347429). In complex with FAAP24, efficiently binds to single-strand DNA (ssDNA), splayed-arm DNA, and 3'-flap substrates (PubMed:17289582). In vitro, on its own, strongly binds ssDNA oligomers and weakly fsDNA, but does not bind to dsDNA (PubMed:16116434). {ECO:0000269|PubMed:16116422, ECO:0000269|PubMed:16116434, ECO:0000269|PubMed:17289582, ECO:0000269|PubMed:19423727, ECO:0000269|PubMed:20347428, ECO:0000269|PubMed:20347429, ECO:0000269|PubMed:29231814}. |
Q8IYH5 | ZZZ3 | S426 | ochoa | ZZ-type zinc finger-containing protein 3 | Histone H3 reader that is required for the ATAC complex-mediated maintenance of histone acetylation and gene activation (PubMed:30217978). Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4 (PubMed:19103755). {ECO:0000269|PubMed:19103755, ECO:0000269|PubMed:30217978}. |
Q8IYL3 | C1orf174 | S145 | ochoa | UPF0688 protein C1orf174 | None |
Q8N3C0 | ASCC3 | S139 | ochoa | Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200) | ATPase involved both in DNA repair and rescue of stalled ribosomes (PubMed:22055184, PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). 3'-5' DNA helicase involved in repair of alkylated DNA: promotes DNA unwinding to generate single-stranded substrate needed for ALKBH3, enabling ALKBH3 to process alkylated N3-methylcytosine (3mC) within double-stranded regions (PubMed:22055184). Also involved in activation of the ribosome quality control (RQC) pathway, a pathway that degrades nascent peptide chains during problematic translation (PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). Drives the splitting of stalled ribosomes that are ubiquitinated in a ZNF598-dependent manner, as part of the ribosome quality control trigger (RQT) complex (PubMed:28757607, PubMed:32099016, PubMed:32579943, PubMed:36302773). Part of the ASC-1 complex that enhances NF-kappa-B, SRF and AP1 transactivation (PubMed:12077347). {ECO:0000269|PubMed:12077347, ECO:0000269|PubMed:22055184, ECO:0000269|PubMed:28757607, ECO:0000269|PubMed:32099016, ECO:0000269|PubMed:32579943, ECO:0000269|PubMed:36302773}. |
Q8N3K9 | CMYA5 | S362 | ochoa | Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) | May serve as an anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) via binding to PRKAR2A (By similarity). May function as a repressor of calcineurin-mediated transcriptional activity. May attenuate calcineurin ability to induce slow-fiber gene program in muscle and may negatively modulate skeletal muscle regeneration (By similarity). Plays a role in the assembly of ryanodine receptor (RYR2) clusters in striated muscle (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q70KF4}. |
Q8ND82 | ZNF280C | S115 | ochoa | Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633) | May function as a transcription factor. |
Q8NFT8 | DNER | S688 | ochoa | Delta and Notch-like epidermal growth factor-related receptor | Activator of the NOTCH1 pathway. May mediate neuron-glia interaction during astrocytogenesis (By similarity). {ECO:0000250}. |
Q8TCU6 | PREX1 | S1191 | ochoa | Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (P-Rex1) (PtdIns(3,4,5)-dependent Rac exchanger 1) | Functions as a RAC guanine nucleotide exchange factor (GEF), which activates the Rac proteins by exchanging bound GDP for free GTP. Its activity is synergistically activated by phosphatidylinositol 3,4,5-trisphosphate and the beta gamma subunits of heterotrimeric G protein. May function downstream of heterotrimeric G proteins in neutrophils. |
Q8WX93 | PALLD | S1333 | ochoa | Palladin (SIH002) (Sarcoma antigen NY-SAR-77) | Cytoskeletal protein required for organization of normal actin cytoskeleton. Roles in establishing cell morphology, motility, cell adhesion and cell-extracellular matrix interactions in a variety of cell types. May function as a scaffolding molecule with the potential to influence both actin polymerization and the assembly of existing actin filaments into higher-order arrays. Binds to proteins that bind to either monomeric or filamentous actin. Localizes at sites where active actin remodeling takes place, such as lamellipodia and membrane ruffles. Different isoforms may have functional differences. Involved in the control of morphological and cytoskeletal changes associated with dendritic cell maturation. Involved in targeting ACTN to specific subcellular foci. {ECO:0000269|PubMed:11598191, ECO:0000269|PubMed:15147863, ECO:0000269|PubMed:17537434}. |
Q8WXG6 | MADD | S156 | ochoa | MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (Rab3GEP) | Guanyl-nucleotide exchange factor that regulates small GTPases of the Rab family (PubMed:18559336, PubMed:20937701). Converts GDP-bound inactive form of RAB27A and RAB27B to the GTP-bound active forms (PubMed:18559336, PubMed:20937701). Converts GDP-bound inactive form of RAB3A, RAB3C and RAB3D to the GTP-bound active forms, GTPases involved in synaptic vesicle exocytosis and vesicle secretion (By similarity). Plays a role in synaptic vesicle formation and in vesicle trafficking at the neuromuscular junction (By similarity). Involved in up-regulating a post-docking step of synaptic exocytosis in central synapses (By similarity). Probably by binding to the motor proteins KIF1B and KIF1A, mediates motor-dependent transport of GTP-RAB3A-positive vesicles to the presynaptic nerve terminals (By similarity). Plays a role in TNFA-mediated activation of the MAPK pathway, including ERK1/2 (PubMed:32761064). May link TNFRSF1A with MAP kinase activation (PubMed:9115275). May be involved in the regulation of TNFA-induced apoptosis (PubMed:11577081, PubMed:32761064). {ECO:0000250|UniProtKB:O08873, ECO:0000250|UniProtKB:Q80U28, ECO:0000269|PubMed:11577081, ECO:0000269|PubMed:18559336, ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:32761064, ECO:0000269|PubMed:9115275}. |
Q8WY36 | BBX | S559 | ochoa | HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2) | Transcription factor that is necessary for cell cycle progression from G1 to S phase. {ECO:0000269|PubMed:11680820}. |
Q92610 | ZNF592 | S529 | ochoa | Zinc finger protein 592 | May be involved in transcriptional regulation. {ECO:0000269|PubMed:20531441}. |
Q96EV2 | RBM33 | S739 | ochoa | RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33) | RNA reader protein, which recognizes and binds specific RNAs, thereby regulating RNA metabolic processes, such as mRNA export, mRNA stability and/or translation (PubMed:35589130, PubMed:37257451). Binds a subset of intronless RNAs containing GC-rich elements, such as NORAD, and promotes their nuclear export by recruiting target RNAs to components of the NXF1-NXT1 RNA export machinery (PubMed:35589130). Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, promoting their demethylation by ALKBH5 (PubMed:37257451). Acts as an molecular adapter, which (1) promotes ALKBH5 recruitment to m6A-containing transcripts and (2) activates ALKBH5 demethylase activity by recruiting SENP1, leading to ALKBH5 deSUMOylation and subsequent activation (PubMed:37257451). {ECO:0000269|PubMed:35589130, ECO:0000269|PubMed:37257451}. |
Q96II8 | LRCH3 | S611 | ochoa | DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3) | As part of the DISP complex, may regulate the association of septins with actin and thereby regulate the actin cytoskeleton. {ECO:0000269|PubMed:29467281}. |
Q96KR1 | ZFR | S195 | ochoa | Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog) | Involved in postimplantation and gastrulation stages of development. Involved in the nucleocytoplasmic shuttling of STAU2. Binds to DNA and RNA (By similarity). {ECO:0000250}. |
Q96MT3 | PRICKLE1 | S379 | ochoa | Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1) | Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. Convergent extension is a complex morphogenetic process during which cells elongate, move mediolaterally, and intercalate between neighboring cells, leading to convergence toward the mediolateral axis and extension along the anteroposterior axis. Necessary for nuclear localization of REST. May serve as nuclear receptor. {ECO:0000269|PubMed:21901791}. |
Q96RV3 | PCNX1 | S159 | ochoa | Pecanex-like protein 1 (Pecanex homolog protein 1) | None |
Q96S59 | RANBP9 | S534 | ochoa | Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7) | May act as scaffolding protein, and as adapter protein to couple membrane receptors to intracellular signaling pathways (Probable). Acts as a mediator of cell spreading and actin cytoskeleton rearrangement (PubMed:18710924). Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1 (PubMed:29911972). May be involved in signaling of ITGB2/LFA-1 and other integrins (PubMed:14722085). Enhances HGF-MET signaling by recruiting Sos and activating the Ras pathway (PubMed:12147692). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but not affect estrogen-induced transactivation (PubMed:12361945, PubMed:18222118). Stabilizes TP73 isoform Alpha, probably by inhibiting its ubiquitination, and increases its proapoptotic activity (PubMed:15558019). Inhibits the kinase activity of DYRK1A and DYRK1B. Inhibits FMR1 binding to RNA. {ECO:0000269|PubMed:12147692, ECO:0000269|PubMed:12361945, ECO:0000269|PubMed:14500717, ECO:0000269|PubMed:14722085, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118, ECO:0000269|PubMed:18710924, ECO:0000269|PubMed:29911972, ECO:0000305}. |
Q9BX66 | SORBS1 | S143 | ochoa | Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP) | Plays a role in tyrosine phosphorylation of CBL by linking CBL to the insulin receptor. Required for insulin-stimulated glucose transport. Involved in formation of actin stress fibers and focal adhesions (By similarity). {ECO:0000250|UniProtKB:Q62417}. |
Q9H6R7 | WDCP | S501 | ochoa | WD repeat and coiled-coil-containing protein | None |
Q9H6W3 | RIOX1 | S63 | ochoa | Ribosomal oxygenase 1 (60S ribosomal protein L8 histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.27, EC 1.14.11.79) (Myc-associated protein with JmjC domain) (Nucleolar protein 66) (hsNO66) (Ribosomal oxygenase NO66) (ROX) | Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase (PubMed:23103944). Specifically demethylates 'Lys-4' (H3K4me) and 'Lys-36' (H3K36me) of histone H3, thereby playing a central role in histone code (By similarity). Preferentially demethylates trimethylated H3 'Lys-4' (H3K4me3) and monomethylated H3 'Lys-4' (H3K4me1) residues, while it has weaker activity for dimethylated H3 'Lys-36' (H3K36me2) (By similarity). Acts as a regulator of osteoblast differentiation via its interaction with SP7/OSX by demethylating H3K4me and H3K36me, thereby inhibiting SP7/OSX-mediated promoter activation (By similarity). Also catalyzes demethylation of non-histone proteins, such as CGAS: demethylation of monomethylated CGAS promotes interaction between CGAS and PARP1, followed by PARP1 inactivation (By similarity). Also catalyzes the hydroxylation of 60S ribosomal protein L8 on 'His-216', thereby playing a role in ribosome biogenesis (PubMed:23103944). Participates in MYC-induced transcriptional activation (PubMed:17308053). {ECO:0000250|UniProtKB:Q9JJF3, ECO:0000269|PubMed:17308053, ECO:0000269|PubMed:23103944}. |
Q9H9J4 | USP42 | S494 | ochoa | Ubiquitin carboxyl-terminal hydrolase 42 (EC 3.4.19.12) (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42) | Deubiquitinating enzyme which may play an important role during spermatogenesis. {ECO:0000250}. |
Q9HCD5 | NCOA5 | S529 | ochoa | Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) | Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2). {ECO:0000269|PubMed:15073177}. |
Q9HCD6 | TANC2 | S169 | ochoa | Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2) | Scaffolding protein in the dendritic spines which acts as immobile postsynaptic posts able to recruit KIF1A-driven dense core vesicles to dendritic spines. {ECO:0000269|PubMed:30021165}. |
Q9HCJ0 | TNRC6C | S1672 | ochoa | Trinucleotide repeat-containing gene 6C protein | Plays a role in RNA-mediated gene silencing by micro-RNAs (miRNAs). Required for miRNA-dependent translational repression of complementary mRNAs by argonaute family proteins. As scaffoldng protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes. {ECO:0000269|PubMed:19304925, ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:21984184, ECO:0000269|PubMed:21984185}. |
Q9HCK8 | CHD8 | S440 | ochoa | Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.-) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1) | ATP-dependent chromatin-remodeling factor, it slides nucleosomes along DNA; nucleosome sliding requires ATP (PubMed:28533432). Acts as a transcription repressor by remodeling chromatin structure and recruiting histone H1 to target genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1 and preventing p53/TP53 transactivation activity. Acts as a negative regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) activity. Negatively regulates CTNNB1-targeted gene expression by being recruited specifically to the promoter regions of several CTNNB1 responsive genes. Involved in both enhancer blocking and epigenetic remodeling at chromatin boundary via its interaction with CTCF. Acts as a suppressor of STAT3 activity by suppressing the LIF-induced STAT3 transcriptional activity. Also acts as a transcription activator via its interaction with ZNF143 by participating in efficient U6 RNA polymerase III transcription. Regulates alternative splicing of a core group of genes involved in neuronal differentiation, cell cycle and DNA repair. Enables H3K36me3-coupled transcription elongation and co-transcriptional RNA processing likely via interaction with HNRNPL. {ECO:0000255|HAMAP-Rule:MF_03071, ECO:0000269|PubMed:17938208, ECO:0000269|PubMed:18378692, ECO:0000269|PubMed:28533432, ECO:0000269|PubMed:36537238}. |
Q9NR00 | TCIM | S21 | ochoa | Transcriptional and immune response regulator (Thyroid cancer protein 1) (TC-1) | Seems to be involved in the regulation of cell growth an differentiation, may play different and opposite roles depending on the tissue or cell type. May enhance the WNT-CTNNB1 pathway by relieving antagonistic activity of CBY1 (PubMed:16424001, PubMed:16730711). Enhances the proliferation of follicular dendritic cells (PubMed:16730711). Plays a role in the mitogen-activated MAPK2/3 signaling pathway, positively regulates G1-to-S-phase transition of the cell cycle (PubMed:18959821). In endothelial cells, enhances key inflammatory mediators and inflammatory response through the modulation of NF-kappaB transcriptional regulatory activity (PubMed:19684084). Involved in the regulation of heat shock response, seems to play a positive feedback with HSF1 to modulate heat-shock downstream gene expression (PubMed:17603013). Plays a role in the regulation of hematopoiesis even if the mechanisms are unknown (By similarity). In cancers such as thyroid or lung cancer, it has been described as promoter of cell proliferation, G1-to-S-phase transition and inhibitor of apoptosis (PubMed:15087392, PubMed:24941347). However, it negatively regulates self-renewal of liver cancer cells via suppresion of NOTCH2 signaling (PubMed:25985737). {ECO:0000250|UniProtKB:Q9D915, ECO:0000269|PubMed:15087392, ECO:0000269|PubMed:16424001, ECO:0000269|PubMed:16730711, ECO:0000269|PubMed:17603013, ECO:0000269|PubMed:18959821, ECO:0000269|PubMed:19684084, ECO:0000269|PubMed:24941347, ECO:0000269|PubMed:25985737, ECO:0000305}. |
Q9NVA4 | TMEM184C | S344 | ochoa | Transmembrane protein 184C (Transmembrane protein 34) | Possible tumor suppressor which may play a role in cell growth. {ECO:0000269|PubMed:17072649}. |
Q9P0V3 | SH3BP4 | S42 | ochoa | SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein) | May function in transferrin receptor internalization at the plasma membrane through a cargo-specific control of clathrin-mediated endocytosis. Alternatively, may act as a negative regulator of the amino acid-induced TOR signaling by inhibiting the formation of active Rag GTPase complexes. Preferentially binds inactive Rag GTPase complexes and prevents their interaction with the mTORC1 complex inhibiting its relocalization to lysosomes and its activation. Thereby, may indirectly regulate cell growth, proliferation and autophagy. {ECO:0000269|PubMed:16325581, ECO:0000269|PubMed:22575674}. |
Q9UBL0 | ARPP21 | S364 | ochoa | cAMP-regulated phosphoprotein 21 (ARPP-21) (Thymocyte cAMP-regulated phosphoprotein) | Isoform 2 may act as a competitive inhibitor of calmodulin-dependent enzymes such as calcineurin in neurons. {ECO:0000250}. |
Q9UHV7 | MED13 | S890 | ochoa | Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250) | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}. |
Q9UKX2 | MYH2 | S20 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX2 | MYH2 | S174 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UPP1 | PHF8 | S793 | ochoa | Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) | Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Only has activity toward H4K20Me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. Positively modulates transcription of histone demethylase KDM5C, acting synergistically with transcription factor ARX; synergy may be related to enrichment of histone H3K4me3 in regulatory elements. {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20531378, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854, ECO:0000269|PubMed:31691806}. |
Q9UPQ9 | TNRC6B | S421 | ochoa | Trinucleotide repeat-containing gene 6B protein | Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs) (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). Required for miRNA-dependent translational repression and siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). As scaffolding protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes (PubMed:21981923). {ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:19167051, ECO:0000269|PubMed:19304925, ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:32354837}. |
Q9UQB3 | CTNND2 | S201 | ochoa | Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) | Has a critical role in neuronal development, particularly in the formation and/or maintenance of dendritic spines and synapses (PubMed:25807484). Involved in the regulation of Wnt signaling (PubMed:25807484). It probably acts on beta-catenin turnover, facilitating beta-catenin interaction with GSK3B, phosphorylation, ubiquitination and degradation (By similarity). Functions as a transcriptional activator when bound to ZBTB33 (By similarity). May be involved in neuronal cell adhesion and tissue morphogenesis and integrity by regulating adhesion molecules. {ECO:0000250|UniProtKB:O35927, ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9971746}. |
Q9Y2F5 | ICE1 | S393 | ochoa | Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) | Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically acts as a scaffold protein that promotes the LEC complex formation and recruitment and RNA polymerase II occupancy at snRNA genes in subnuclear bodies (PubMed:23932780). {ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780}. |
Q9Y2X7 | GIT1 | S414 | ochoa|psp | ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1) | GTPase-activating protein for ADP ribosylation factor family members, including ARF1. Multidomain scaffold protein that interacts with numerous proteins and therefore participates in many cellular functions, including receptor internalization, focal adhesion remodeling, and signaling by both G protein-coupled receptors and tyrosine kinase receptors (By similarity). Through PAK1 activation, positively regulates microtubule nucleation during interphase (PubMed:27012601). Plays a role in the regulation of cytokinesis; for this function, may act in a pathway also involving ENTR1 and PTPN13 (PubMed:23108400). May promote cell motility both by regulating focal complex dynamics and by local activation of RAC1 (PubMed:10938112, PubMed:11896197). May act as scaffold for MAPK1/3 signal transduction in focal adhesions. Recruits MAPK1/3/ERK1/2 to focal adhesions after EGF stimulation via a Src-dependent pathway, hence stimulating cell migration (PubMed:15923189). Plays a role in brain development and function. Involved in the regulation of spine density and synaptic plasticity that is required for processes involved in learning (By similarity). Plays an important role in dendritic spine morphogenesis and synapse formation (PubMed:12695502, PubMed:15800193). In hippocampal neurons, recruits guanine nucleotide exchange factors (GEFs), such as ARHGEF7/beta-PIX, to the synaptic membrane. These in turn locally activate RAC1, which is an essential step for spine morphogenesis and synapse formation (PubMed:12695502). May contribute to the organization of presynaptic active zones through oligomerization and formation of a Piccolo/PCLO-based protein network, which includes ARHGEF7/beta-PIX and FAK1 (By similarity). In neurons, through its interaction with liprin-alpha family members, may be required for AMPA receptor (GRIA2/3) proper targeting to the cell membrane (By similarity). In complex with GABA(A) receptors and ARHGEF7, plays a crucial role in regulating GABA(A) receptor synaptic stability, maintaining GPHN/gephyrin scaffolds and hence GABAergic inhibitory synaptic transmission, by locally coordinating RAC1 and PAK1 downstream effector activity, leading to F-actin stabilization (PubMed:25284783). May also be important for RAC1 downstream signaling pathway through PAK3 and regulation of neuronal inhibitory transmission at presynaptic input (By similarity). Required for successful bone regeneration during fracture healing (By similarity). The function in intramembranous ossification may, at least partly, exerted by macrophages in which GIT1 is a key negative regulator of redox homeostasis, IL1B production, and glycolysis, acting through the ERK1/2/NRF2/NFE2L2 axis (By similarity). May play a role in angiogenesis during fracture healing (By similarity). In this process, may regulate activation of the canonical NF-kappa-B signal in bone mesenchymal stem cells by enhancing the interaction between NEMO and 'Lys-63'-ubiquitinated RIPK1/RIP1, eventually leading to enhanced production of VEGFA and others angiogenic factors (PubMed:31502302). Essential for VEGF signaling through the activation of phospholipase C-gamma and ERK1/2, hence may control endothelial cell proliferation and angiogenesis (PubMed:19273721). {ECO:0000250|UniProtKB:Q68FF6, ECO:0000250|UniProtKB:Q9Z272, ECO:0000269|PubMed:10938112, ECO:0000269|PubMed:11896197, ECO:0000269|PubMed:12695502, ECO:0000269|PubMed:15800193, ECO:0000269|PubMed:15923189, ECO:0000269|PubMed:19273721, ECO:0000269|PubMed:23108400, ECO:0000269|PubMed:25284783, ECO:0000269|PubMed:27012601, ECO:0000269|PubMed:31502302}. |
Q9Y623 | MYH4 | S174 | ochoa | Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal) | Muscle contraction. |
Q9ULL1 | PLEKHG1 | S615 | Sugiyama | Pleckstrin homology domain-containing family G member 1 | None |
P05023 | ATP1A1 | S757 | Sugiyama | Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients (PubMed:29499166, PubMed:30388404). Could also be part of an osmosensory signaling pathway that senses body-fluid sodium levels and controls salt intake behavior as well as voluntary water intake to regulate sodium homeostasis (By similarity). {ECO:0000250|UniProtKB:Q8VDN2, ECO:0000269|PubMed:29499166, ECO:0000269|PubMed:30388404}. |
P13637 | ATP1A3 | S747 | Sugiyama | Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:33880529}. |
P50993 | ATP1A2 | S754 | Sugiyama | Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:33880529}. |
Q13733 | ATP1A4 | S763 | Sugiyama | Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. Plays a role in sperm motility. |
P05787 | KRT8 | S258 | Sugiyama | Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8) | Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. {ECO:0000269|PubMed:16000376}. |
Q9H6F5 | CCDC86 | S136 | Sugiyama | Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain) | Required for proper chromosome segregation during mitosis and error-free mitotic progression. {ECO:0000269|PubMed:36695333}. |
P33992 | MCM5 | S483 | Sugiyama | DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232}. |
P35579 | MYH9 | S169 | Sugiyama | Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Required for cortical actin clearance prior to oocyte exocytosis (By similarity). Promotes cell motility in conjunction with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanically antagonized by MYH10 (PubMed:20052411). {ECO:0000250|UniProtKB:Q8VDD5, ECO:0000269|PubMed:16707441, ECO:0000269|PubMed:20052411}.; FUNCTION: (Microbial infection) Acts as a receptor for herpes simplex virus 1/HHV-1 envelope glycoprotein B. {ECO:0000269|PubMed:20944748, ECO:0000269|PubMed:39048823}. |
Q14566 | MCM6 | S498 | Sugiyama | DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
O15013 | ARHGEF10 | S1330 | Sugiyama | Rho guanine nucleotide exchange factor 10 | May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}. |
Q99614 | TTC1 | S155 | Sugiyama | Tetratricopeptide repeat protein 1 (TPR repeat protein 1) | None |
P33992 | MCM5 | S424 | Sugiyama | DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232}. |
P11388 | TOP2A | S390 | Sugiyama | DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme) | Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:17567603, PubMed:18790802, PubMed:22013166, PubMed:22323612). May play a role in regulating the period length of BMAL1 transcriptional oscillation (By similarity). {ECO:0000250|UniProtKB:Q01320, ECO:0000269|PubMed:17567603, ECO:0000269|PubMed:18790802, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22323612}. |
Q8N0Z6 | TTC5 | S203 | SIGNOR | Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap) | Cofactor involved in the regulation of various cellular mechanisms such as actin regulation, autophagy, chromatin regulation and DNA repair (PubMed:18451878, PubMed:31727855). In non-stress conditions, interacts with cofactor JMY in the cytoplasm which prevents JMY's actin nucleation activity and ability to activate the Arp2/3 complex. Acts as a negative regulator of nutrient stress-induced autophagy by preventing JMY's interaction with MAP1LC3B, thereby preventing autophagosome formation (By similarity). Involves in tubulin autoregulation by promoting its degradation in response to excess soluble tubulin (PubMed:31727855). To do so, associates with the active ribosome near the ribosome exit tunnel and with nascent tubulin polypeptides early during their translation, triggering tubulin mRNA-targeted degradation (PubMed:31727855). Following DNA damage, phosphorylated by DNA damage responsive protein kinases ATM and CHEK2, leading to its nuclear accumulation and stability. Nuclear TTC5/STRAP promotes the assembly of a stress-responsive p53/TP53 coactivator complex, which includes the coactivators JMY and p300, thereby increasing p53/TP53-dependent transcription and apoptosis. Also recruits arginine methyltransferase PRMT5 to p53/TP53 when DNA is damaged, allowing PRMT5 to methylate p53/TP53. In DNA stress conditions, also prevents p53/TP53 degradation by E3 ubiquitin ligase MDM2 (By similarity). Upon heat-shock stress, forms a chromatin-associated complex with heat-shock factor 1 HSF1 and p300/EP300 to stimulate heat-shock-responsive transcription, thereby increasing cell survival (PubMed:18451878). Mitochondrial TTC5/STRAP interacts with ATP synthase subunit beta ATP5F1B which decreased ATP synthase activity and lowers mitochondrial ATP production, thereby regulating cellular respiration and mitochondrial-dependent apoptosis. Mitochondrial TTC5/STRAP also regulates p53/TP53-mediated apoptosis (By similarity). {ECO:0000250|UniProtKB:Q99LG4, ECO:0000269|PubMed:18451878, ECO:0000269|PubMed:31727855}. |
P35580 | MYH10 | S173 | Sugiyama | Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB) | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. During cell spreading, plays an important role in cytoskeleton reorganization, focal contacts formation (in the central part but not the margins of spreading cells), and lamellipodial extension; this function is mechanically antagonized by MYH9. {ECO:0000269|PubMed:20052411, ECO:0000269|PubMed:20603131}.; FUNCTION: (Microbial infection) Acts as a receptor for herpes simplex virus 1/HHV-1 envelope glycoprotein B. {ECO:0000305|PubMed:25428876, ECO:0000305|PubMed:39048823}. |
P35749 | MYH11 | S173 | Sugiyama | Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC) | Muscle contraction. |
Q7Z406 | MYH14 | S193 | Sugiyama | Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C) | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. {ECO:0000250}. |
Q8N6H7 | ARFGAP2 | S123 | Sugiyama | ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289) | GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes. {ECO:0000269|PubMed:17760859}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-8851708 | Signaling by FGFR2 IIIa TM | 1.204508e-07 | 6.919 |
R-HSA-1839126 | FGFR2 mutant receptor activation | 1.861755e-07 | 6.730 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 1.348678e-06 | 5.870 |
R-HSA-3928663 | EPHA-mediated growth cone collapse | 1.565821e-05 | 4.805 |
R-HSA-1226099 | Signaling by FGFR in disease | 1.268125e-05 | 4.897 |
R-HSA-2682334 | EPH-Ephrin signaling | 5.018588e-05 | 4.299 |
R-HSA-397014 | Muscle contraction | 6.458171e-05 | 4.190 |
R-HSA-5654221 | Phospholipase C-mediated cascade; FGFR2 | 9.328075e-05 | 4.030 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 9.328075e-05 | 4.030 |
R-HSA-190241 | FGFR2 ligand binding and activation | 1.083524e-04 | 3.965 |
R-HSA-5654695 | PI-3K cascade:FGFR2 | 2.113342e-04 | 3.675 |
R-HSA-9839394 | TGFBR3 expression | 2.113342e-04 | 3.675 |
R-HSA-176974 | Unwinding of DNA | 2.020662e-04 | 3.695 |
R-HSA-400685 | Sema4D in semaphorin signaling | 2.113342e-04 | 3.675 |
R-HSA-5654699 | SHC-mediated cascade:FGFR2 | 2.675566e-04 | 3.573 |
R-HSA-5654700 | FRS-mediated FGFR2 signaling | 2.993610e-04 | 3.524 |
R-HSA-373755 | Semaphorin interactions | 5.462680e-04 | 3.263 |
R-HSA-390522 | Striated Muscle Contraction | 5.496102e-04 | 3.260 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 6.023871e-04 | 3.220 |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | 6.586636e-04 | 3.181 |
R-HSA-2023837 | Signaling by FGFR2 amplification mutants | 1.017592e-03 | 2.992 |
R-HSA-2033519 | Activated point mutants of FGFR2 | 1.321603e-03 | 2.879 |
R-HSA-5654738 | Signaling by FGFR2 | 1.411381e-03 | 2.850 |
R-HSA-9839373 | Signaling by TGFBR3 | 1.653571e-03 | 2.782 |
R-HSA-426496 | Post-transcriptional silencing by small RNAs | 1.970615e-03 | 2.705 |
R-HSA-109704 | PI3K Cascade | 2.139508e-03 | 2.670 |
R-HSA-68949 | Orc1 removal from chromatin | 2.415958e-03 | 2.617 |
R-HSA-8869496 | TFAP2A acts as a transcriptional repressor during retinoic acid induced cell dif... | 3.218627e-03 | 2.492 |
R-HSA-193648 | NRAGE signals death through JNK | 3.040741e-03 | 2.517 |
R-HSA-5578775 | Ion homeostasis | 3.040741e-03 | 2.517 |
R-HSA-112399 | IRS-mediated signalling | 3.212617e-03 | 2.493 |
R-HSA-190236 | Signaling by FGFR | 3.532237e-03 | 2.452 |
R-HSA-68962 | Activation of the pre-replicative complex | 4.646867e-03 | 2.333 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 4.306894e-03 | 2.366 |
R-HSA-936837 | Ion transport by P-type ATPases | 4.604493e-03 | 2.337 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 4.135116e-03 | 2.384 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 3.966381e-03 | 2.402 |
R-HSA-2428924 | IGF1R signaling cascade | 4.604493e-03 | 2.337 |
R-HSA-74751 | Insulin receptor signalling cascade | 4.604493e-03 | 2.337 |
R-HSA-9768778 | Regulation of NPAS4 mRNA translation | 4.750709e-03 | 2.323 |
R-HSA-9825895 | Regulation of MITF-M-dependent genes involved in DNA replication, damage repair ... | 4.750709e-03 | 2.323 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 4.831659e-03 | 2.316 |
R-HSA-69190 | DNA strand elongation | 5.392966e-03 | 2.268 |
R-HSA-73887 | Death Receptor Signaling | 5.402210e-03 | 2.267 |
R-HSA-176187 | Activation of ATR in response to replication stress | 5.791415e-03 | 2.237 |
R-HSA-9759811 | Regulation of CDH11 mRNA translation by microRNAs | 7.558305e-03 | 2.122 |
R-HSA-190377 | FGFR2b ligand binding and activation | 7.558305e-03 | 2.122 |
R-HSA-69052 | Switching of origins to a post-replicative state | 6.924707e-03 | 2.160 |
R-HSA-163765 | ChREBP activates metabolic gene expression | 7.558305e-03 | 2.122 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 6.924707e-03 | 2.160 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 8.045218e-03 | 2.094 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 8.165577e-03 | 2.088 |
R-HSA-69278 | Cell Cycle, Mitotic | 8.286416e-03 | 2.082 |
R-HSA-416482 | G alpha (12/13) signalling events | 8.497081e-03 | 2.071 |
R-HSA-5467333 | APC truncation mutants are not K63 polyubiquitinated | 9.149010e-03 | 2.039 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 1.017179e-02 | 1.993 |
R-HSA-3214841 | PKMTs methylate histone lysines | 1.017179e-02 | 1.993 |
R-HSA-190375 | FGFR2c ligand binding and activation | 1.094658e-02 | 1.961 |
R-HSA-9029558 | NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | 1.094658e-02 | 1.961 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 1.219926e-02 | 1.914 |
R-HSA-8948700 | Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 1.351157e-02 | 1.869 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 1.391986e-02 | 1.856 |
R-HSA-9708530 | Regulation of BACH1 activity | 1.488231e-02 | 1.827 |
R-HSA-74752 | Signaling by Insulin receptor | 1.503967e-02 | 1.823 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 1.532103e-02 | 1.815 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 1.602998e-02 | 1.795 |
R-HSA-9768759 | Regulation of NPAS4 gene expression | 1.779446e-02 | 1.750 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 1.924328e-02 | 1.716 |
R-HSA-9856651 | MITF-M-dependent gene expression | 2.007815e-02 | 1.697 |
R-HSA-5683057 | MAPK family signaling cascades | 2.075446e-02 | 1.683 |
R-HSA-1266738 | Developmental Biology | 2.156893e-02 | 1.666 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 2.169689e-02 | 1.664 |
R-HSA-9909620 | Regulation of PD-L1(CD274) translation | 2.257241e-02 | 1.646 |
R-HSA-1362277 | Transcription of E2F targets under negative control by DREAM complex | 2.257241e-02 | 1.646 |
R-HSA-8853333 | Signaling by FGFR2 fusions | 2.719835e-02 | 1.565 |
R-HSA-5339700 | Signaling by TCF7L2 mutants | 2.719835e-02 | 1.565 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 2.426989e-02 | 1.615 |
R-HSA-69239 | Synthesis of DNA | 2.476420e-02 | 1.606 |
R-HSA-162582 | Signal Transduction | 2.655134e-02 | 1.576 |
R-HSA-195721 | Signaling by WNT | 2.834193e-02 | 1.548 |
R-HSA-8943723 | Regulation of PTEN mRNA translation | 2.966188e-02 | 1.528 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 3.141151e-02 | 1.503 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 3.235937e-02 | 1.490 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 3.470187e-02 | 1.460 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 3.816364e-02 | 1.418 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 3.548147e-02 | 1.450 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 3.358596e-02 | 1.474 |
R-HSA-69206 | G1/S Transition | 4.104781e-02 | 1.387 |
R-HSA-4086398 | Ca2+ pathway | 3.935537e-02 | 1.405 |
R-HSA-68875 | Mitotic Prophase | 3.590143e-02 | 1.445 |
R-HSA-525793 | Myogenesis | 3.548147e-02 | 1.450 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 3.358596e-02 | 1.474 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 3.842492e-02 | 1.415 |
R-HSA-422475 | Axon guidance | 3.691627e-02 | 1.433 |
R-HSA-1640170 | Cell Cycle | 3.724818e-02 | 1.429 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 3.427425e-02 | 1.465 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 4.170175e-02 | 1.380 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 4.564033e-02 | 1.341 |
R-HSA-9659379 | Sensory processing of sound | 4.689754e-02 | 1.329 |
R-HSA-9734767 | Developmental Cell Lineages | 4.754840e-02 | 1.323 |
R-HSA-5576891 | Cardiac conduction | 4.755464e-02 | 1.323 |
R-HSA-4791275 | Signaling by WNT in cancer | 4.829693e-02 | 1.316 |
R-HSA-1538133 | G0 and Early G1 | 4.829693e-02 | 1.316 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 4.829693e-02 | 1.316 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 5.057434e-02 | 1.296 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 5.057434e-02 | 1.296 |
R-HSA-9675108 | Nervous system development | 5.249700e-02 | 1.280 |
R-HSA-389948 | Co-inhibition by PD-1 | 5.257125e-02 | 1.279 |
R-HSA-9768727 | Regulation of CDH1 posttranslational processing and trafficking to plasma membra... | 5.288976e-02 | 1.277 |
R-HSA-5603029 | IkBA variant leads to EDA-ID | 7.090561e-02 | 1.149 |
R-HSA-9927426 | Developmental Lineage of Mammary Gland Alveolar Cells | 5.524232e-02 | 1.258 |
R-HSA-8939247 | RUNX1 regulates transcription of genes involved in interleukin signaling | 6.232308e-02 | 1.205 |
R-HSA-8939245 | RUNX1 regulates transcription of genes involved in BCR signaling | 6.232308e-02 | 1.205 |
R-HSA-68867 | Assembly of the pre-replicative complex | 7.016654e-02 | 1.154 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 5.763116e-02 | 1.239 |
R-HSA-3134963 | DEx/H-box helicases activate type I IFN and inflammatory cytokines production | 6.232308e-02 | 1.205 |
R-HSA-69242 | S Phase | 6.792142e-02 | 1.168 |
R-HSA-2559585 | Oncogene Induced Senescence | 5.763116e-02 | 1.239 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 5.356167e-02 | 1.271 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 6.492172e-02 | 1.188 |
R-HSA-9679191 | Potential therapeutics for SARS | 7.029139e-02 | 1.153 |
R-HSA-5673001 | RAF/MAP kinase cascade | 6.676720e-02 | 1.175 |
R-HSA-1257604 | PIP3 activates AKT signaling | 7.176412e-02 | 1.144 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 7.261743e-02 | 1.139 |
R-HSA-69306 | DNA Replication | 7.392534e-02 | 1.131 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 7.794827e-02 | 1.108 |
R-HSA-9006936 | Signaling by TGFB family members | 8.276797e-02 | 1.082 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 8.333357e-02 | 1.079 |
R-HSA-8951430 | RUNX3 regulates WNT signaling | 8.783729e-02 | 1.056 |
R-HSA-4411364 | Binding of TCF/LEF:CTNNB1 to target gene promoters | 8.783729e-02 | 1.056 |
R-HSA-112126 | ALKBH3 mediated reversal of alkylation damage | 9.618783e-02 | 1.017 |
R-HSA-4839744 | Signaling by APC mutants | 1.207866e-01 | 0.918 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 1.207866e-01 | 0.918 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 1.207866e-01 | 0.918 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 1.207866e-01 | 0.918 |
R-HSA-9931512 | Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | 1.288375e-01 | 0.890 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 1.288375e-01 | 0.890 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 1.238096e-01 | 0.907 |
R-HSA-164843 | 2-LTR circle formation | 1.126618e-01 | 0.948 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 9.161656e-02 | 1.038 |
R-HSA-9032845 | Activated NTRK2 signals through CDK5 | 8.783729e-02 | 1.056 |
R-HSA-4839735 | Signaling by AXIN mutants | 1.288375e-01 | 0.890 |
R-HSA-4839748 | Signaling by AMER1 mutants | 1.288375e-01 | 0.890 |
R-HSA-69002 | DNA Replication Pre-Initiation | 1.013472e-01 | 0.994 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 9.948878e-02 | 1.002 |
R-HSA-9619229 | Activation of RAC1 downstream of NMDARs | 1.044624e-01 | 0.981 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 1.167551e-01 | 0.933 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 1.288375e-01 | 0.890 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 1.059213e-01 | 0.975 |
R-HSA-445355 | Smooth Muscle Contraction | 1.088512e-01 | 0.963 |
R-HSA-9006925 | Intracellular signaling by second messengers | 1.180719e-01 | 0.928 |
R-HSA-448706 | Interleukin-1 processing | 1.044624e-01 | 0.981 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 1.238096e-01 | 0.907 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 1.120400e-01 | 0.951 |
R-HSA-162592 | Integration of provirus | 1.288375e-01 | 0.890 |
R-HSA-5689880 | Ub-specific processing proteases | 1.019282e-01 | 0.992 |
R-HSA-9662834 | CD163 mediating an anti-inflammatory response | 1.207866e-01 | 0.918 |
R-HSA-3247509 | Chromatin modifying enzymes | 8.624008e-02 | 1.064 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 9.618783e-02 | 1.017 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 9.764438e-02 | 1.010 |
R-HSA-4839726 | Chromatin organization | 1.034593e-01 | 0.985 |
R-HSA-9700206 | Signaling by ALK in cancer | 9.764438e-02 | 1.010 |
R-HSA-421270 | Cell-cell junction organization | 1.058763e-01 | 0.975 |
R-HSA-5688426 | Deubiquitination | 1.107935e-01 | 0.955 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 1.019282e-01 | 0.992 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 1.019282e-01 | 0.992 |
R-HSA-211000 | Gene Silencing by RNA | 9.764438e-02 | 1.010 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 1.059213e-01 | 0.975 |
R-HSA-983712 | Ion channel transport | 1.260801e-01 | 0.899 |
R-HSA-75153 | Apoptotic execution phase | 8.882918e-02 | 1.051 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 8.882918e-02 | 1.051 |
R-HSA-75893 | TNF signaling | 1.177668e-01 | 0.929 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 1.330101e-01 | 0.876 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 1.330101e-01 | 0.876 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 1.368152e-01 | 0.864 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 1.368152e-01 | 0.864 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 1.368152e-01 | 0.864 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 1.368152e-01 | 0.864 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 1.368152e-01 | 0.864 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 1.603154e-01 | 0.795 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 1.680067e-01 | 0.775 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 1.980785e-01 | 0.703 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 2.199216e-01 | 0.658 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 2.199216e-01 | 0.658 |
R-HSA-6803529 | FGFR2 alternative splicing | 2.270704e-01 | 0.644 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 2.341542e-01 | 0.630 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 2.341542e-01 | 0.630 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 2.618504e-01 | 0.582 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 2.618504e-01 | 0.582 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 2.618504e-01 | 0.582 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 2.686175e-01 | 0.571 |
R-HSA-113418 | Formation of the Early Elongation Complex | 2.686175e-01 | 0.571 |
R-HSA-167287 | HIV elongation arrest and recovery | 2.686175e-01 | 0.571 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 2.686175e-01 | 0.571 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 2.550210e-01 | 0.593 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 1.614533e-01 | 0.792 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 2.175631e-01 | 0.662 |
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 1.756281e-01 | 0.755 |
R-HSA-4641265 | Repression of WNT target genes | 1.368152e-01 | 0.864 |
R-HSA-3928664 | Ephrin signaling | 1.906633e-01 | 0.720 |
R-HSA-399956 | CRMPs in Sema3A signaling | 1.525535e-01 | 0.817 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 2.111144e-01 | 0.675 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 1.603154e-01 | 0.795 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 1.906633e-01 | 0.720 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 1.906633e-01 | 0.720 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 2.411735e-01 | 0.618 |
R-HSA-6807878 | COPI-mediated anterograde transport | 2.581199e-01 | 0.588 |
R-HSA-73943 | Reversal of alkylation damage by DNA dioxygenases | 1.368152e-01 | 0.864 |
R-HSA-9620244 | Long-term potentiation | 2.481290e-01 | 0.605 |
R-HSA-162587 | HIV Life Cycle | 2.182548e-01 | 0.661 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 2.270704e-01 | 0.644 |
R-HSA-73942 | DNA Damage Reversal | 1.603154e-01 | 0.795 |
R-HSA-6809371 | Formation of the cornified envelope | 1.349429e-01 | 0.870 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 2.581199e-01 | 0.588 |
R-HSA-212165 | Epigenetic regulation of gene expression | 2.093505e-01 | 0.679 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 2.344136e-01 | 0.630 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 2.127070e-01 | 0.672 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 2.411735e-01 | 0.618 |
R-HSA-420029 | Tight junction interactions | 2.481290e-01 | 0.605 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 2.618504e-01 | 0.582 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 2.199216e-01 | 0.658 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 2.550210e-01 | 0.593 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 1.916094e-01 | 0.718 |
R-HSA-8851805 | MET activates RAS signaling | 1.368152e-01 | 0.864 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 1.603154e-01 | 0.795 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 2.063839e-01 | 0.685 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 1.906633e-01 | 0.720 |
R-HSA-438064 | Post NMDA receptor activation events | 2.209252e-01 | 0.656 |
R-HSA-3214842 | HDMs demethylate histones | 2.481290e-01 | 0.605 |
R-HSA-9823730 | Formation of definitive endoderm | 2.054262e-01 | 0.687 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 2.199216e-01 | 0.658 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 2.411735e-01 | 0.618 |
R-HSA-8863678 | Neurodegenerative Diseases | 2.411735e-01 | 0.618 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.673111e-01 | 0.776 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 1.711677e-01 | 0.767 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 2.618504e-01 | 0.582 |
R-HSA-8852135 | Protein ubiquitination | 1.776974e-01 | 0.750 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 2.087461e-01 | 0.680 |
R-HSA-9629569 | Protein hydroxylation | 2.054262e-01 | 0.687 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 2.550210e-01 | 0.593 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 2.411735e-01 | 0.618 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 1.373438e-01 | 0.862 |
R-HSA-69481 | G2/M Checkpoints | 1.433490e-01 | 0.844 |
R-HSA-68886 | M Phase | 1.681002e-01 | 0.774 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 1.614533e-01 | 0.792 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 2.618504e-01 | 0.582 |
R-HSA-418990 | Adherens junctions interactions | 1.769865e-01 | 0.752 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 2.344136e-01 | 0.630 |
R-HSA-446728 | Cell junction organization | 1.411336e-01 | 0.850 |
R-HSA-1989781 | PPARA activates gene expression | 2.134887e-01 | 0.671 |
R-HSA-3000170 | Syndecan interactions | 2.341542e-01 | 0.630 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 2.182548e-01 | 0.661 |
R-HSA-1500931 | Cell-Cell communication | 1.980784e-01 | 0.703 |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | 2.481290e-01 | 0.605 |
R-HSA-844456 | The NLRP3 inflammasome | 1.980785e-01 | 0.703 |
R-HSA-1834941 | STING mediated induction of host immune responses | 1.980785e-01 | 0.703 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 2.127070e-01 | 0.672 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 2.108535e-01 | 0.676 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 1.392281e-01 | 0.856 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 1.785708e-01 | 0.748 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 1.908685e-01 | 0.719 |
R-HSA-9664417 | Leishmania phagocytosis | 1.763020e-01 | 0.754 |
R-HSA-9664407 | Parasite infection | 1.763020e-01 | 0.754 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 1.763020e-01 | 0.754 |
R-HSA-622312 | Inflammasomes | 2.686175e-01 | 0.571 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 2.620132e-01 | 0.582 |
R-HSA-73894 | DNA Repair | 2.719831e-01 | 0.565 |
R-HSA-72086 | mRNA Capping | 2.753230e-01 | 0.560 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 2.753230e-01 | 0.560 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 2.772430e-01 | 0.557 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 2.784732e-01 | 0.555 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 2.784732e-01 | 0.555 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 2.819675e-01 | 0.550 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 2.819675e-01 | 0.550 |
R-HSA-888590 | GABA synthesis, release, reuptake and degradation | 2.819675e-01 | 0.550 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 2.885514e-01 | 0.540 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 2.885514e-01 | 0.540 |
R-HSA-2129379 | Molecules associated with elastic fibres | 2.885514e-01 | 0.540 |
R-HSA-9833110 | RSV-host interactions | 2.886407e-01 | 0.540 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 2.950754e-01 | 0.530 |
R-HSA-9658195 | Leishmania infection | 3.001073e-01 | 0.523 |
R-HSA-9824443 | Parasitic Infection Pathways | 3.001073e-01 | 0.523 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 3.015399e-01 | 0.521 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 3.015399e-01 | 0.521 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 3.015399e-01 | 0.521 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 3.079456e-01 | 0.512 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 3.079456e-01 | 0.512 |
R-HSA-8964539 | Glutamate and glutamine metabolism | 3.079456e-01 | 0.512 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 3.079456e-01 | 0.512 |
R-HSA-180746 | Nuclear import of Rev protein | 3.142929e-01 | 0.503 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 3.190237e-01 | 0.496 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 3.205824e-01 | 0.494 |
R-HSA-212300 | PRC2 methylates histones and DNA | 3.268146e-01 | 0.486 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 3.290906e-01 | 0.483 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 3.329900e-01 | 0.478 |
R-HSA-5689896 | Ovarian tumor domain proteases | 3.329900e-01 | 0.478 |
R-HSA-373760 | L1CAM interactions | 3.357800e-01 | 0.474 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 3.391091e-01 | 0.470 |
R-HSA-1566948 | Elastic fibre formation | 3.391091e-01 | 0.470 |
R-HSA-6805567 | Keratinization | 3.443333e-01 | 0.463 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 3.451725e-01 | 0.462 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 3.451725e-01 | 0.462 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 3.451725e-01 | 0.462 |
R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 3.451725e-01 | 0.462 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 3.457773e-01 | 0.461 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 3.511806e-01 | 0.454 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 3.511806e-01 | 0.454 |
R-HSA-167169 | HIV Transcription Elongation | 3.511806e-01 | 0.454 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 3.511806e-01 | 0.454 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 3.511806e-01 | 0.454 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 3.511806e-01 | 0.454 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 3.511806e-01 | 0.454 |
R-HSA-5260271 | Diseases of Immune System | 3.511806e-01 | 0.454 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 3.511806e-01 | 0.454 |
R-HSA-8982491 | Glycogen metabolism | 3.511806e-01 | 0.454 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 3.571339e-01 | 0.447 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 3.571339e-01 | 0.447 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 3.571339e-01 | 0.447 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 3.630330e-01 | 0.440 |
R-HSA-167161 | HIV Transcription Initiation | 3.630330e-01 | 0.440 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 3.630330e-01 | 0.440 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 3.630330e-01 | 0.440 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 3.653465e-01 | 0.437 |
R-HSA-400508 | Incretin synthesis, secretion, and inactivation | 3.688783e-01 | 0.433 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 3.746704e-01 | 0.426 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 3.804096e-01 | 0.420 |
R-HSA-69236 | G1 Phase | 3.804096e-01 | 0.420 |
R-HSA-69231 | Cyclin D associated events in G1 | 3.804096e-01 | 0.420 |
R-HSA-3928662 | EPHB-mediated forward signaling | 3.804096e-01 | 0.420 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 3.860965e-01 | 0.413 |
R-HSA-6783310 | Fanconi Anemia Pathway | 3.860965e-01 | 0.413 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 3.860965e-01 | 0.413 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 3.860965e-01 | 0.413 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 3.860965e-01 | 0.413 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 3.917316e-01 | 0.407 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 3.917316e-01 | 0.407 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 3.917316e-01 | 0.407 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 3.917316e-01 | 0.407 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 3.917316e-01 | 0.407 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 3.949453e-01 | 0.403 |
R-HSA-162906 | HIV Infection | 3.965798e-01 | 0.402 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 3.973153e-01 | 0.401 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 4.028481e-01 | 0.395 |
R-HSA-163685 | Integration of energy metabolism | 4.109726e-01 | 0.386 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 4.141535e-01 | 0.383 |
R-HSA-199991 | Membrane Trafficking | 4.180499e-01 | 0.379 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 4.191455e-01 | 0.378 |
R-HSA-6807070 | PTEN Regulation | 4.204899e-01 | 0.376 |
R-HSA-8939211 | ESR-mediated signaling | 4.211076e-01 | 0.376 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 4.244792e-01 | 0.372 |
R-HSA-6794361 | Neurexins and neuroligins | 4.244792e-01 | 0.372 |
R-HSA-157118 | Signaling by NOTCH | 4.284042e-01 | 0.368 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 4.297643e-01 | 0.367 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 4.297643e-01 | 0.367 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 4.297643e-01 | 0.367 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 4.297643e-01 | 0.367 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 4.330578e-01 | 0.363 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 4.485626e-01 | 0.348 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 4.504267e-01 | 0.346 |
R-HSA-194441 | Metabolism of non-coding RNA | 4.604773e-01 | 0.337 |
R-HSA-191859 | snRNP Assembly | 4.604773e-01 | 0.337 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 4.607954e-01 | 0.336 |
R-HSA-983189 | Kinesins | 4.654340e-01 | 0.332 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 4.698667e-01 | 0.328 |
R-HSA-69620 | Cell Cycle Checkpoints | 4.714537e-01 | 0.327 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 4.728703e-01 | 0.325 |
R-HSA-6784531 | tRNA processing in the nucleus | 4.752119e-01 | 0.323 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 4.752119e-01 | 0.323 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 4.800341e-01 | 0.319 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 4.800341e-01 | 0.319 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 4.800341e-01 | 0.319 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 4.848122e-01 | 0.314 |
R-HSA-109581 | Apoptosis | 4.936084e-01 | 0.307 |
R-HSA-8854518 | AURKA Activation by TPX2 | 4.942381e-01 | 0.306 |
R-HSA-167172 | Transcription of the HIV genome | 5.034926e-01 | 0.298 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 5.125789e-01 | 0.290 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 5.125789e-01 | 0.290 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 5.125789e-01 | 0.290 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 5.170600e-01 | 0.286 |
R-HSA-3000178 | ECM proteoglycans | 5.170600e-01 | 0.286 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 5.170600e-01 | 0.286 |
R-HSA-453276 | Regulation of mitotic cell cycle | 5.170600e-01 | 0.286 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 5.215001e-01 | 0.283 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 5.215001e-01 | 0.283 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 5.223320e-01 | 0.282 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 5.258996e-01 | 0.279 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 5.258996e-01 | 0.279 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 5.302590e-01 | 0.276 |
R-HSA-380287 | Centrosome maturation | 5.345786e-01 | 0.272 |
R-HSA-1169408 | ISG15 antiviral mechanism | 5.345786e-01 | 0.272 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 5.345786e-01 | 0.272 |
R-HSA-1980143 | Signaling by NOTCH1 | 5.388587e-01 | 0.269 |
R-HSA-168255 | Influenza Infection | 5.445198e-01 | 0.264 |
R-HSA-2559583 | Cellular Senescence | 5.472428e-01 | 0.262 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 5.473019e-01 | 0.262 |
R-HSA-4086400 | PCP/CE pathway | 5.473019e-01 | 0.262 |
R-HSA-216083 | Integrin cell surface interactions | 5.473019e-01 | 0.262 |
R-HSA-9833482 | PKR-mediated signaling | 5.555917e-01 | 0.255 |
R-HSA-6806834 | Signaling by MET | 5.555917e-01 | 0.255 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 5.637306e-01 | 0.249 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 5.677443e-01 | 0.246 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 5.717214e-01 | 0.243 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 5.717214e-01 | 0.243 |
R-HSA-6794362 | Protein-protein interactions at synapses | 5.756622e-01 | 0.240 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 5.795669e-01 | 0.237 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 5.834359e-01 | 0.234 |
R-HSA-70268 | Pyruvate metabolism | 5.872696e-01 | 0.231 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 5.910682e-01 | 0.228 |
R-HSA-9645723 | Diseases of programmed cell death | 5.910682e-01 | 0.228 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 5.985616e-01 | 0.223 |
R-HSA-112310 | Neurotransmitter release cycle | 5.985616e-01 | 0.223 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 5.993105e-01 | 0.222 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 6.042648e-01 | 0.219 |
R-HSA-112315 | Transmission across Chemical Synapses | 6.127220e-01 | 0.213 |
R-HSA-9679506 | SARS-CoV Infections | 6.133640e-01 | 0.212 |
R-HSA-5357801 | Programmed Cell Death | 6.140351e-01 | 0.212 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 6.202331e-01 | 0.207 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 6.202331e-01 | 0.207 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 6.271955e-01 | 0.203 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 6.271955e-01 | 0.203 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 6.306290e-01 | 0.200 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 6.306911e-01 | 0.200 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 6.340311e-01 | 0.198 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 6.340311e-01 | 0.198 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 6.340311e-01 | 0.198 |
R-HSA-3214847 | HATs acetylate histones | 6.374020e-01 | 0.196 |
R-HSA-1643685 | Disease | 6.376312e-01 | 0.195 |
R-HSA-70171 | Glycolysis | 6.407422e-01 | 0.193 |
R-HSA-5653656 | Vesicle-mediated transport | 6.436734e-01 | 0.191 |
R-HSA-9020702 | Interleukin-1 signaling | 6.440517e-01 | 0.191 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 6.473310e-01 | 0.189 |
R-HSA-1280218 | Adaptive Immune System | 6.522656e-01 | 0.186 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 6.537998e-01 | 0.185 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 6.558992e-01 | 0.183 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 6.601507e-01 | 0.180 |
R-HSA-74160 | Gene expression (Transcription) | 6.632169e-01 | 0.178 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 6.694608e-01 | 0.174 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 6.725075e-01 | 0.172 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 6.755263e-01 | 0.170 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 6.755263e-01 | 0.170 |
R-HSA-1483249 | Inositol phosphate metabolism | 6.814813e-01 | 0.167 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 6.844179e-01 | 0.165 |
R-HSA-597592 | Post-translational protein modification | 6.897826e-01 | 0.161 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 6.930675e-01 | 0.159 |
R-HSA-9007101 | Rab regulation of trafficking | 7.014815e-01 | 0.154 |
R-HSA-70326 | Glucose metabolism | 7.014815e-01 | 0.154 |
R-HSA-2980736 | Peptide hormone metabolism | 7.014815e-01 | 0.154 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 7.069632e-01 | 0.151 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 7.069632e-01 | 0.151 |
R-HSA-3371556 | Cellular response to heat stress | 7.123448e-01 | 0.147 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 7.149987e-01 | 0.146 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 7.149987e-01 | 0.146 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 7.176283e-01 | 0.144 |
R-HSA-2132295 | MHC class II antigen presentation | 7.176283e-01 | 0.144 |
R-HSA-162909 | Host Interactions of HIV factors | 7.202338e-01 | 0.143 |
R-HSA-977606 | Regulation of Complement cascade | 7.228154e-01 | 0.141 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 7.253734e-01 | 0.139 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 7.253734e-01 | 0.139 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 7.253734e-01 | 0.139 |
R-HSA-114608 | Platelet degranulation | 7.304191e-01 | 0.136 |
R-HSA-9824446 | Viral Infection Pathways | 7.351291e-01 | 0.134 |
R-HSA-9843745 | Adipogenesis | 7.426343e-01 | 0.129 |
R-HSA-9711123 | Cellular response to chemical stress | 7.443362e-01 | 0.128 |
R-HSA-9909396 | Circadian clock | 7.450105e-01 | 0.128 |
R-HSA-1474228 | Degradation of the extracellular matrix | 7.450105e-01 | 0.128 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 7.473649e-01 | 0.126 |
R-HSA-9948299 | Ribosome-associated quality control | 7.610449e-01 | 0.119 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 7.628063e-01 | 0.118 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 7.676403e-01 | 0.115 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 7.718810e-01 | 0.112 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 7.739889e-01 | 0.111 |
R-HSA-166658 | Complement cascade | 7.781469e-01 | 0.109 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 7.842418e-01 | 0.106 |
R-HSA-166520 | Signaling by NTRKs | 7.842418e-01 | 0.106 |
R-HSA-9758941 | Gastrulation | 7.862362e-01 | 0.104 |
R-HSA-212436 | Generic Transcription Pathway | 7.901163e-01 | 0.102 |
R-HSA-446652 | Interleukin-1 family signaling | 7.921103e-01 | 0.101 |
R-HSA-9610379 | HCMV Late Events | 8.015463e-01 | 0.096 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 8.033818e-01 | 0.095 |
R-HSA-9711097 | Cellular response to starvation | 8.033818e-01 | 0.095 |
R-HSA-5663205 | Infectious disease | 8.035049e-01 | 0.095 |
R-HSA-73857 | RNA Polymerase II Transcription | 8.054780e-01 | 0.094 |
R-HSA-5633007 | Regulation of TP53 Activity | 8.070024e-01 | 0.093 |
R-HSA-5619102 | SLC transporter disorders | 8.191607e-01 | 0.087 |
R-HSA-72306 | tRNA processing | 8.257636e-01 | 0.083 |
R-HSA-8957322 | Metabolism of steroids | 8.268414e-01 | 0.083 |
R-HSA-112316 | Neuronal System | 8.300981e-01 | 0.081 |
R-HSA-9664433 | Leishmania parasite growth and survival | 8.305580e-01 | 0.081 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 8.305580e-01 | 0.081 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 8.336813e-01 | 0.079 |
R-HSA-1474244 | Extracellular matrix organization | 8.352856e-01 | 0.078 |
R-HSA-69275 | G2/M Transition | 8.498644e-01 | 0.071 |
R-HSA-453274 | Mitotic G2-G2/M phases | 8.526341e-01 | 0.069 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 8.526341e-01 | 0.069 |
R-HSA-5617833 | Cilium Assembly | 8.553530e-01 | 0.068 |
R-HSA-168898 | Toll-like Receptor Cascades | 8.566937e-01 | 0.067 |
R-HSA-68877 | Mitotic Prometaphase | 8.593381e-01 | 0.066 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 8.606422e-01 | 0.065 |
R-HSA-9609690 | HCMV Early Events | 8.632142e-01 | 0.064 |
R-HSA-72172 | mRNA Splicing | 8.742174e-01 | 0.058 |
R-HSA-168249 | Innate Immune System | 8.807033e-01 | 0.055 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 8.880891e-01 | 0.052 |
R-HSA-913531 | Interferon Signaling | 8.880891e-01 | 0.052 |
R-HSA-8951664 | Neddylation | 8.926578e-01 | 0.049 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 8.994461e-01 | 0.046 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 9.013060e-01 | 0.045 |
R-HSA-72312 | rRNA processing | 9.031318e-01 | 0.044 |
R-HSA-5619115 | Disorders of transmembrane transporters | 9.157970e-01 | 0.038 |
R-HSA-446203 | Asparagine N-linked glycosylation | 9.164652e-01 | 0.038 |
R-HSA-9609646 | HCMV Infection | 9.181252e-01 | 0.037 |
R-HSA-2262752 | Cellular responses to stress | 9.208069e-01 | 0.036 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 9.345898e-01 | 0.029 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.350788e-01 | 0.029 |
R-HSA-6798695 | Neutrophil degranulation | 9.360712e-01 | 0.029 |
R-HSA-388396 | GPCR downstream signalling | 9.375355e-01 | 0.028 |
R-HSA-168256 | Immune System | 9.448449e-01 | 0.025 |
R-HSA-392499 | Metabolism of proteins | 9.470366e-01 | 0.024 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 9.575040e-01 | 0.019 |
R-HSA-8953897 | Cellular responses to stimuli | 9.609847e-01 | 0.017 |
R-HSA-372790 | Signaling by GPCR | 9.633307e-01 | 0.016 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.651132e-01 | 0.015 |
R-HSA-9694516 | SARS-CoV-2 Infection | 9.676415e-01 | 0.014 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.719016e-01 | 0.012 |
R-HSA-8978868 | Fatty acid metabolism | 9.814428e-01 | 0.008 |
R-HSA-382551 | Transport of small molecules | 9.841594e-01 | 0.007 |
R-HSA-72766 | Translation | 9.849257e-01 | 0.007 |
R-HSA-8953854 | Metabolism of RNA | 9.865559e-01 | 0.006 |
R-HSA-109582 | Hemostasis | 9.955577e-01 | 0.002 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.975030e-01 | 0.001 |
R-HSA-449147 | Signaling by Interleukins | 9.976648e-01 | 0.001 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 9.979259e-01 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 9.986206e-01 | 0.001 |
R-HSA-9709957 | Sensory Perception | 9.994582e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
COT |
0.843 | 0.074 | 2 | 0.818 |
CLK3 |
0.841 | 0.239 | 1 | 0.813 |
NLK |
0.841 | 0.211 | 1 | 0.852 |
CDC7 |
0.833 | -0.033 | 1 | 0.767 |
TBK1 |
0.832 | 0.012 | 1 | 0.718 |
CAMK1B |
0.832 | 0.048 | -3 | 0.784 |
PIM3 |
0.832 | 0.038 | -3 | 0.775 |
MTOR |
0.831 | 0.001 | 1 | 0.765 |
HIPK4 |
0.831 | 0.130 | 1 | 0.809 |
PRKD1 |
0.830 | 0.043 | -3 | 0.754 |
NDR2 |
0.830 | 0.014 | -3 | 0.786 |
ERK5 |
0.830 | 0.088 | 1 | 0.794 |
ATR |
0.829 | 0.072 | 1 | 0.822 |
NUAK2 |
0.829 | 0.052 | -3 | 0.770 |
AMPKA1 |
0.829 | 0.095 | -3 | 0.788 |
ULK2 |
0.829 | -0.040 | 2 | 0.745 |
GCN2 |
0.829 | -0.102 | 2 | 0.741 |
TSSK1 |
0.829 | 0.127 | -3 | 0.813 |
NDR1 |
0.829 | 0.044 | -3 | 0.772 |
PRKD2 |
0.828 | 0.071 | -3 | 0.714 |
PRPK |
0.828 | -0.157 | -1 | 0.825 |
CDKL1 |
0.828 | 0.043 | -3 | 0.714 |
RAF1 |
0.828 | -0.054 | 1 | 0.784 |
CDKL5 |
0.828 | 0.065 | -3 | 0.708 |
RSK2 |
0.828 | 0.068 | -3 | 0.705 |
PKN3 |
0.828 | 0.039 | -3 | 0.751 |
KIS |
0.828 | 0.158 | 1 | 0.783 |
TSSK2 |
0.827 | 0.103 | -5 | 0.791 |
ICK |
0.827 | 0.132 | -3 | 0.751 |
DYRK2 |
0.827 | 0.213 | 1 | 0.776 |
MOS |
0.826 | -0.031 | 1 | 0.788 |
SRPK1 |
0.826 | 0.097 | -3 | 0.671 |
IKKE |
0.826 | -0.031 | 1 | 0.713 |
P90RSK |
0.826 | 0.037 | -3 | 0.703 |
PKCD |
0.826 | 0.103 | 2 | 0.723 |
RIPK3 |
0.826 | 0.019 | 3 | 0.733 |
TGFBR2 |
0.826 | 0.008 | -2 | 0.784 |
IKKB |
0.826 | -0.078 | -2 | 0.751 |
WNK1 |
0.825 | 0.035 | -2 | 0.855 |
CAMLCK |
0.825 | 0.085 | -2 | 0.882 |
DAPK2 |
0.825 | 0.097 | -3 | 0.781 |
PDHK4 |
0.825 | -0.211 | 1 | 0.800 |
CDK8 |
0.825 | 0.174 | 1 | 0.764 |
MAPKAPK3 |
0.825 | 0.008 | -3 | 0.714 |
MARK4 |
0.824 | 0.026 | 4 | 0.844 |
NIK |
0.824 | 0.033 | -3 | 0.805 |
CLK1 |
0.824 | 0.182 | -3 | 0.680 |
AMPKA2 |
0.824 | 0.082 | -3 | 0.761 |
PDHK1 |
0.824 | -0.121 | 1 | 0.803 |
BMPR2 |
0.823 | -0.125 | -2 | 0.864 |
RSK3 |
0.823 | 0.031 | -3 | 0.700 |
PKN2 |
0.823 | 0.038 | -3 | 0.758 |
CLK4 |
0.823 | 0.171 | -3 | 0.698 |
NEK6 |
0.823 | 0.001 | -2 | 0.851 |
SRPK2 |
0.822 | 0.091 | -3 | 0.601 |
JNK2 |
0.822 | 0.235 | 1 | 0.726 |
LATS2 |
0.822 | 0.005 | -5 | 0.679 |
CDK7 |
0.822 | 0.161 | 1 | 0.760 |
NUAK1 |
0.822 | 0.059 | -3 | 0.734 |
PKACG |
0.822 | 0.088 | -2 | 0.796 |
SKMLCK |
0.822 | 0.055 | -2 | 0.856 |
CAMK4 |
0.822 | 0.049 | -3 | 0.755 |
MST4 |
0.821 | 0.011 | 2 | 0.763 |
MELK |
0.821 | 0.074 | -3 | 0.743 |
WNK3 |
0.821 | -0.031 | 1 | 0.761 |
MNK2 |
0.821 | 0.098 | -2 | 0.836 |
PIM1 |
0.821 | 0.049 | -3 | 0.720 |
CDK19 |
0.820 | 0.172 | 1 | 0.733 |
P70S6KB |
0.820 | 0.047 | -3 | 0.726 |
NEK7 |
0.820 | -0.063 | -3 | 0.720 |
NIM1 |
0.820 | 0.012 | 3 | 0.764 |
DSTYK |
0.819 | -0.083 | 2 | 0.795 |
CHK1 |
0.819 | 0.077 | -3 | 0.797 |
AURC |
0.819 | 0.118 | -2 | 0.716 |
ULK1 |
0.819 | -0.074 | -3 | 0.716 |
CAMK2G |
0.818 | -0.112 | 2 | 0.740 |
CAMK2D |
0.817 | -0.049 | -3 | 0.756 |
PRKD3 |
0.817 | 0.050 | -3 | 0.673 |
CDK5 |
0.817 | 0.191 | 1 | 0.764 |
CDK18 |
0.817 | 0.192 | 1 | 0.692 |
JNK3 |
0.817 | 0.216 | 1 | 0.746 |
AURB |
0.817 | 0.136 | -2 | 0.720 |
MLK1 |
0.817 | -0.073 | 2 | 0.748 |
P38A |
0.817 | 0.191 | 1 | 0.770 |
MAPKAPK2 |
0.817 | -0.007 | -3 | 0.681 |
PAK3 |
0.816 | 0.061 | -2 | 0.829 |
PAK6 |
0.816 | 0.107 | -2 | 0.787 |
ANKRD3 |
0.815 | 0.005 | 1 | 0.817 |
IRE2 |
0.815 | 0.047 | 2 | 0.732 |
QIK |
0.815 | 0.012 | -3 | 0.746 |
QSK |
0.815 | 0.040 | 4 | 0.826 |
IKKA |
0.815 | -0.005 | -2 | 0.723 |
HIPK1 |
0.814 | 0.201 | 1 | 0.780 |
P38B |
0.814 | 0.205 | 1 | 0.722 |
HIPK2 |
0.814 | 0.201 | 1 | 0.708 |
CHAK2 |
0.814 | -0.047 | -1 | 0.799 |
HIPK3 |
0.814 | 0.189 | 1 | 0.793 |
MASTL |
0.814 | -0.168 | -2 | 0.825 |
PAK1 |
0.813 | 0.066 | -2 | 0.819 |
MNK1 |
0.813 | 0.090 | -2 | 0.844 |
PKG2 |
0.813 | 0.108 | -2 | 0.737 |
DYRK1A |
0.813 | 0.165 | 1 | 0.799 |
CDK17 |
0.813 | 0.193 | 1 | 0.650 |
HUNK |
0.813 | -0.133 | 2 | 0.773 |
SIK |
0.813 | 0.030 | -3 | 0.697 |
CDK1 |
0.812 | 0.186 | 1 | 0.714 |
GRK5 |
0.812 | -0.164 | -3 | 0.778 |
MLK2 |
0.812 | -0.058 | 2 | 0.748 |
SRPK3 |
0.812 | 0.054 | -3 | 0.637 |
NEK9 |
0.812 | -0.105 | 2 | 0.768 |
PHKG1 |
0.812 | -0.012 | -3 | 0.759 |
IRE1 |
0.812 | -0.044 | 1 | 0.713 |
ERK1 |
0.812 | 0.184 | 1 | 0.720 |
CDK13 |
0.812 | 0.143 | 1 | 0.736 |
DYRK3 |
0.811 | 0.202 | 1 | 0.784 |
PLK1 |
0.811 | 0.030 | -2 | 0.835 |
P38G |
0.811 | 0.200 | 1 | 0.652 |
ERK2 |
0.811 | 0.182 | 1 | 0.741 |
SGK3 |
0.811 | 0.097 | -3 | 0.689 |
LATS1 |
0.811 | 0.050 | -3 | 0.799 |
RIPK1 |
0.810 | -0.111 | 1 | 0.757 |
MSK2 |
0.810 | 0.014 | -3 | 0.657 |
BRSK2 |
0.810 | -0.017 | -3 | 0.747 |
DLK |
0.810 | -0.101 | 1 | 0.785 |
CDK14 |
0.810 | 0.199 | 1 | 0.727 |
BCKDK |
0.810 | -0.177 | -1 | 0.774 |
ATM |
0.809 | 0.018 | 1 | 0.784 |
PAK2 |
0.809 | 0.066 | -2 | 0.815 |
CDK2 |
0.809 | 0.134 | 1 | 0.763 |
DYRK4 |
0.809 | 0.198 | 1 | 0.723 |
CLK2 |
0.809 | 0.168 | -3 | 0.700 |
MYLK4 |
0.809 | 0.059 | -2 | 0.811 |
RSK4 |
0.809 | 0.054 | -3 | 0.686 |
PKACB |
0.809 | 0.104 | -2 | 0.737 |
GRK6 |
0.809 | -0.083 | 1 | 0.768 |
AKT2 |
0.808 | 0.075 | -3 | 0.621 |
ALK4 |
0.808 | 0.000 | -2 | 0.797 |
MARK2 |
0.808 | 0.028 | 4 | 0.749 |
MSK1 |
0.808 | 0.062 | -3 | 0.672 |
DYRK1B |
0.808 | 0.192 | 1 | 0.729 |
PKCA |
0.807 | 0.021 | 2 | 0.663 |
CAMK2B |
0.807 | -0.029 | 2 | 0.688 |
PKCG |
0.807 | 0.002 | 2 | 0.681 |
MARK3 |
0.807 | 0.021 | 4 | 0.784 |
CDK3 |
0.806 | 0.192 | 1 | 0.667 |
PIM2 |
0.806 | 0.044 | -3 | 0.678 |
P38D |
0.806 | 0.208 | 1 | 0.685 |
PKR |
0.806 | -0.022 | 1 | 0.766 |
VRK2 |
0.806 | -0.009 | 1 | 0.835 |
PLK4 |
0.806 | 0.002 | 2 | 0.644 |
CDK9 |
0.806 | 0.126 | 1 | 0.740 |
PKCB |
0.805 | -0.003 | 2 | 0.676 |
MEK1 |
0.805 | -0.082 | 2 | 0.784 |
CDK12 |
0.805 | 0.144 | 1 | 0.719 |
AKT1 |
0.805 | 0.115 | -3 | 0.641 |
BRSK1 |
0.805 | -0.028 | -3 | 0.727 |
AURA |
0.805 | 0.093 | -2 | 0.686 |
DNAPK |
0.804 | 0.041 | 1 | 0.736 |
NEK2 |
0.804 | -0.069 | 2 | 0.753 |
PKCH |
0.804 | -0.004 | 2 | 0.673 |
PKCZ |
0.804 | -0.014 | 2 | 0.721 |
CDK16 |
0.804 | 0.193 | 1 | 0.665 |
CAMK2A |
0.804 | -0.037 | 2 | 0.716 |
MLK3 |
0.804 | -0.056 | 2 | 0.672 |
MARK1 |
0.804 | 0.010 | 4 | 0.807 |
BMPR1B |
0.803 | 0.029 | 1 | 0.705 |
SMG1 |
0.803 | -0.006 | 1 | 0.781 |
SNRK |
0.803 | -0.072 | 2 | 0.695 |
PHKG2 |
0.803 | 0.018 | -3 | 0.734 |
SSTK |
0.803 | 0.059 | 4 | 0.828 |
DCAMKL1 |
0.803 | 0.020 | -3 | 0.735 |
YSK4 |
0.802 | -0.088 | 1 | 0.725 |
TGFBR1 |
0.802 | -0.019 | -2 | 0.758 |
CDK10 |
0.802 | 0.177 | 1 | 0.718 |
SMMLCK |
0.801 | 0.070 | -3 | 0.730 |
PRP4 |
0.801 | 0.073 | -3 | 0.662 |
FAM20C |
0.801 | -0.040 | 2 | 0.505 |
TTBK2 |
0.801 | -0.184 | 2 | 0.660 |
GRK4 |
0.801 | -0.154 | -2 | 0.769 |
PRKX |
0.801 | 0.103 | -3 | 0.636 |
CAMK1G |
0.801 | -0.010 | -3 | 0.682 |
GRK1 |
0.801 | -0.060 | -2 | 0.732 |
CAMK1D |
0.800 | 0.052 | -3 | 0.635 |
WNK4 |
0.800 | -0.009 | -2 | 0.857 |
PLK3 |
0.799 | -0.036 | 2 | 0.729 |
ACVR2A |
0.799 | -0.015 | -2 | 0.768 |
IRAK4 |
0.799 | -0.020 | 1 | 0.733 |
CHAK1 |
0.799 | -0.107 | 2 | 0.722 |
MLK4 |
0.799 | -0.051 | 2 | 0.657 |
TLK2 |
0.799 | -0.020 | 1 | 0.766 |
PKCT |
0.798 | 0.027 | 2 | 0.676 |
ACVR2B |
0.797 | -0.017 | -2 | 0.778 |
DCAMKL2 |
0.797 | -0.012 | -3 | 0.755 |
PKACA |
0.797 | 0.087 | -2 | 0.688 |
PERK |
0.796 | -0.086 | -2 | 0.829 |
PAK5 |
0.796 | 0.075 | -2 | 0.713 |
PINK1 |
0.796 | -0.044 | 1 | 0.786 |
HRI |
0.796 | -0.116 | -2 | 0.844 |
P70S6K |
0.796 | -0.003 | -3 | 0.628 |
BRAF |
0.796 | -0.024 | -4 | 0.786 |
CDK4 |
0.796 | 0.184 | 1 | 0.704 |
PKN1 |
0.795 | 0.037 | -3 | 0.644 |
DRAK1 |
0.795 | -0.076 | 1 | 0.696 |
MEKK1 |
0.794 | -0.061 | 1 | 0.797 |
ZAK |
0.794 | -0.052 | 1 | 0.762 |
MAPKAPK5 |
0.794 | -0.118 | -3 | 0.623 |
MEK5 |
0.794 | -0.138 | 2 | 0.772 |
CDK6 |
0.793 | 0.169 | 1 | 0.716 |
CAMK1A |
0.793 | 0.061 | -3 | 0.594 |
PKCI |
0.793 | 0.011 | 2 | 0.691 |
CHK2 |
0.793 | 0.038 | -3 | 0.572 |
MAK |
0.793 | 0.169 | -2 | 0.735 |
MRCKA |
0.793 | 0.126 | -3 | 0.690 |
ALK2 |
0.792 | -0.053 | -2 | 0.772 |
MEKK2 |
0.792 | -0.046 | 2 | 0.748 |
MOK |
0.792 | 0.178 | 1 | 0.765 |
DAPK3 |
0.792 | 0.104 | -3 | 0.732 |
PAK4 |
0.792 | 0.075 | -2 | 0.714 |
GRK7 |
0.792 | -0.032 | 1 | 0.699 |
NEK5 |
0.792 | -0.059 | 1 | 0.773 |
BMPR1A |
0.791 | 0.035 | 1 | 0.690 |
TLK1 |
0.791 | -0.078 | -2 | 0.775 |
JNK1 |
0.790 | 0.160 | 1 | 0.698 |
MST3 |
0.790 | -0.033 | 2 | 0.767 |
MEKK3 |
0.789 | -0.142 | 1 | 0.763 |
ERK7 |
0.789 | 0.035 | 2 | 0.486 |
AKT3 |
0.789 | 0.080 | -3 | 0.560 |
MRCKB |
0.789 | 0.102 | -3 | 0.670 |
SBK |
0.789 | 0.059 | -3 | 0.516 |
PKCE |
0.788 | 0.033 | 2 | 0.666 |
MPSK1 |
0.787 | -0.026 | 1 | 0.714 |
TAO3 |
0.787 | -0.027 | 1 | 0.750 |
ROCK2 |
0.787 | 0.124 | -3 | 0.725 |
SGK1 |
0.787 | 0.071 | -3 | 0.547 |
IRAK1 |
0.785 | -0.148 | -1 | 0.728 |
NEK8 |
0.785 | -0.073 | 2 | 0.773 |
DAPK1 |
0.785 | 0.078 | -3 | 0.703 |
TAO2 |
0.784 | -0.049 | 2 | 0.778 |
BUB1 |
0.784 | 0.069 | -5 | 0.777 |
TTBK1 |
0.784 | -0.134 | 2 | 0.604 |
GRK2 |
0.784 | -0.115 | -2 | 0.651 |
PDK1 |
0.783 | -0.049 | 1 | 0.759 |
MST2 |
0.782 | -0.011 | 1 | 0.767 |
LKB1 |
0.782 | -0.070 | -3 | 0.727 |
GAK |
0.782 | -0.032 | 1 | 0.753 |
DMPK1 |
0.782 | 0.137 | -3 | 0.696 |
NEK4 |
0.782 | -0.072 | 1 | 0.745 |
NEK11 |
0.781 | -0.131 | 1 | 0.767 |
PKG1 |
0.781 | 0.072 | -2 | 0.662 |
CAMKK1 |
0.781 | -0.128 | -2 | 0.780 |
MEKK6 |
0.780 | -0.067 | 1 | 0.753 |
CAMKK2 |
0.780 | -0.089 | -2 | 0.781 |
HGK |
0.780 | -0.025 | 3 | 0.831 |
PASK |
0.779 | -0.080 | -3 | 0.771 |
MAP3K15 |
0.779 | -0.047 | 1 | 0.743 |
LOK |
0.779 | -0.014 | -2 | 0.819 |
CK1E |
0.779 | -0.096 | -3 | 0.479 |
GSK3B |
0.778 | -0.045 | 4 | 0.378 |
MINK |
0.777 | -0.037 | 1 | 0.745 |
GSK3A |
0.777 | -0.001 | 4 | 0.384 |
EEF2K |
0.777 | -0.053 | 3 | 0.807 |
GCK |
0.777 | -0.055 | 1 | 0.746 |
ROCK1 |
0.776 | 0.113 | -3 | 0.689 |
NEK1 |
0.776 | -0.069 | 1 | 0.743 |
RIPK2 |
0.776 | -0.119 | 1 | 0.738 |
TNIK |
0.775 | -0.025 | 3 | 0.833 |
VRK1 |
0.775 | -0.068 | 2 | 0.808 |
LRRK2 |
0.775 | -0.108 | 2 | 0.793 |
CK1G1 |
0.775 | -0.097 | -3 | 0.477 |
MST1 |
0.774 | -0.031 | 1 | 0.741 |
PLK2 |
0.774 | 0.014 | -3 | 0.792 |
TAK1 |
0.773 | -0.090 | 1 | 0.785 |
HPK1 |
0.773 | -0.062 | 1 | 0.737 |
PBK |
0.772 | -0.011 | 1 | 0.680 |
CRIK |
0.771 | 0.053 | -3 | 0.638 |
CK1D |
0.771 | -0.092 | -3 | 0.426 |
MEK2 |
0.771 | -0.145 | 2 | 0.759 |
YSK1 |
0.771 | -0.056 | 2 | 0.737 |
KHS1 |
0.771 | -0.021 | 1 | 0.737 |
SLK |
0.770 | -0.057 | -2 | 0.741 |
KHS2 |
0.769 | -0.006 | 1 | 0.744 |
CK1A2 |
0.769 | -0.087 | -3 | 0.425 |
NEK3 |
0.769 | -0.097 | 1 | 0.740 |
TTK |
0.768 | 0.052 | -2 | 0.810 |
GRK3 |
0.766 | -0.129 | -2 | 0.593 |
STK33 |
0.765 | -0.148 | 2 | 0.595 |
PDHK3_TYR |
0.764 | 0.089 | 4 | 0.866 |
CK2A2 |
0.761 | -0.066 | 1 | 0.600 |
BIKE |
0.759 | -0.023 | 1 | 0.639 |
OSR1 |
0.757 | -0.052 | 2 | 0.734 |
TESK1_TYR |
0.756 | -0.066 | 3 | 0.860 |
LIMK2_TYR |
0.756 | 0.043 | -3 | 0.815 |
MYO3B |
0.755 | -0.055 | 2 | 0.759 |
PKMYT1_TYR |
0.755 | -0.040 | 3 | 0.833 |
HASPIN |
0.754 | -0.056 | -1 | 0.651 |
TAO1 |
0.754 | -0.071 | 1 | 0.702 |
MYO3A |
0.754 | -0.048 | 1 | 0.729 |
PDHK4_TYR |
0.753 | -0.015 | 2 | 0.821 |
ASK1 |
0.753 | -0.112 | 1 | 0.733 |
MAP2K7_TYR |
0.752 | -0.162 | 2 | 0.806 |
MAP2K4_TYR |
0.752 | -0.145 | -1 | 0.845 |
RET |
0.752 | 0.013 | 1 | 0.767 |
CK2A1 |
0.750 | -0.088 | 1 | 0.576 |
MAP2K6_TYR |
0.750 | -0.099 | -1 | 0.846 |
PINK1_TYR |
0.749 | -0.133 | 1 | 0.774 |
TYRO3 |
0.749 | -0.012 | 3 | 0.781 |
BMPR2_TYR |
0.748 | -0.065 | -1 | 0.816 |
ROS1 |
0.748 | -0.002 | 3 | 0.758 |
ALPHAK3 |
0.748 | -0.074 | -1 | 0.733 |
TNNI3K_TYR |
0.747 | 0.069 | 1 | 0.808 |
AAK1 |
0.747 | 0.006 | 1 | 0.543 |
LIMK1_TYR |
0.746 | -0.101 | 2 | 0.796 |
TYK2 |
0.746 | -0.073 | 1 | 0.769 |
MST1R |
0.746 | -0.044 | 3 | 0.787 |
YANK3 |
0.746 | -0.083 | 2 | 0.393 |
CSF1R |
0.746 | -0.003 | 3 | 0.766 |
JAK2 |
0.745 | -0.045 | 1 | 0.780 |
PDHK1_TYR |
0.745 | -0.144 | -1 | 0.856 |
EPHA6 |
0.745 | -0.037 | -1 | 0.811 |
YES1 |
0.745 | 0.013 | -1 | 0.839 |
EPHB4 |
0.745 | -0.029 | -1 | 0.797 |
TXK |
0.743 | 0.041 | 1 | 0.759 |
ITK |
0.743 | 0.020 | -1 | 0.781 |
ABL2 |
0.743 | -0.017 | -1 | 0.809 |
STLK3 |
0.742 | -0.120 | 1 | 0.735 |
JAK3 |
0.741 | -0.048 | 1 | 0.748 |
DDR1 |
0.741 | -0.091 | 4 | 0.797 |
FGR |
0.740 | -0.075 | 1 | 0.771 |
TNK1 |
0.739 | -0.003 | 3 | 0.756 |
TNK2 |
0.739 | -0.023 | 3 | 0.729 |
PDGFRB |
0.739 | -0.030 | 3 | 0.786 |
ABL1 |
0.739 | -0.037 | -1 | 0.806 |
JAK1 |
0.738 | -0.019 | 1 | 0.729 |
FGFR1 |
0.738 | -0.023 | 3 | 0.751 |
SRMS |
0.737 | -0.046 | 1 | 0.785 |
LCK |
0.737 | -0.014 | -1 | 0.806 |
FGFR2 |
0.736 | -0.054 | 3 | 0.769 |
TEK |
0.736 | -0.043 | 3 | 0.709 |
HCK |
0.736 | -0.069 | -1 | 0.810 |
EPHB1 |
0.736 | -0.055 | 1 | 0.801 |
BLK |
0.736 | 0.011 | -1 | 0.822 |
FER |
0.735 | -0.121 | 1 | 0.800 |
AXL |
0.735 | -0.049 | 3 | 0.753 |
NEK10_TYR |
0.735 | -0.089 | 1 | 0.637 |
KDR |
0.734 | -0.049 | 3 | 0.739 |
TEC |
0.734 | -0.017 | -1 | 0.745 |
INSRR |
0.733 | -0.093 | 3 | 0.720 |
KIT |
0.733 | -0.080 | 3 | 0.766 |
EPHB2 |
0.732 | -0.051 | -1 | 0.781 |
BMX |
0.732 | -0.029 | -1 | 0.698 |
PDGFRA |
0.732 | -0.096 | 3 | 0.781 |
FLT3 |
0.732 | -0.087 | 3 | 0.771 |
ALK |
0.731 | -0.045 | 3 | 0.706 |
BTK |
0.731 | -0.100 | -1 | 0.752 |
EPHB3 |
0.731 | -0.103 | -1 | 0.783 |
MERTK |
0.730 | -0.069 | 3 | 0.746 |
EPHA4 |
0.730 | -0.101 | 2 | 0.724 |
DDR2 |
0.730 | 0.025 | 3 | 0.720 |
LTK |
0.729 | -0.057 | 3 | 0.733 |
CK1A |
0.729 | -0.128 | -3 | 0.344 |
MET |
0.729 | -0.079 | 3 | 0.756 |
PTK2B |
0.727 | -0.020 | -1 | 0.785 |
FRK |
0.727 | -0.048 | -1 | 0.825 |
FYN |
0.726 | -0.019 | -1 | 0.783 |
EPHA1 |
0.726 | -0.074 | 3 | 0.732 |
PTK6 |
0.725 | -0.115 | -1 | 0.707 |
EPHA7 |
0.724 | -0.085 | 2 | 0.730 |
FLT4 |
0.723 | -0.100 | 3 | 0.730 |
LYN |
0.723 | -0.067 | 3 | 0.705 |
NTRK1 |
0.723 | -0.158 | -1 | 0.791 |
WEE1_TYR |
0.722 | -0.112 | -1 | 0.700 |
FGFR3 |
0.721 | -0.113 | 3 | 0.738 |
NTRK2 |
0.721 | -0.144 | 3 | 0.727 |
FLT1 |
0.719 | -0.134 | -1 | 0.782 |
EPHA3 |
0.718 | -0.159 | 2 | 0.704 |
INSR |
0.718 | -0.146 | 3 | 0.699 |
SRC |
0.717 | -0.067 | -1 | 0.793 |
ERBB2 |
0.716 | -0.182 | 1 | 0.701 |
MATK |
0.715 | -0.114 | -1 | 0.726 |
NTRK3 |
0.714 | -0.152 | -1 | 0.736 |
EPHA5 |
0.712 | -0.120 | 2 | 0.712 |
CK1G3 |
0.712 | -0.113 | -3 | 0.299 |
EPHA8 |
0.712 | -0.107 | -1 | 0.756 |
CSK |
0.712 | -0.131 | 2 | 0.740 |
EGFR |
0.711 | -0.110 | 1 | 0.631 |
YANK2 |
0.707 | -0.126 | 2 | 0.397 |
PTK2 |
0.705 | -0.072 | -1 | 0.725 |
MUSK |
0.705 | -0.148 | 1 | 0.603 |
FGFR4 |
0.705 | -0.129 | -1 | 0.737 |
EPHA2 |
0.702 | -0.112 | -1 | 0.713 |
IGF1R |
0.702 | -0.143 | 3 | 0.641 |
SYK |
0.699 | -0.108 | -1 | 0.714 |
ERBB4 |
0.695 | -0.119 | 1 | 0.646 |
FES |
0.690 | -0.154 | -1 | 0.678 |
CK1G2 |
0.682 | -0.148 | -3 | 0.392 |
ZAP70 |
0.673 | -0.139 | -1 | 0.640 |